KR20090017655A - 환자가 면역치료제에 대한 반응자일지의 여부를 확인하는 방법 - Google Patents
환자가 면역치료제에 대한 반응자일지의 여부를 확인하는 방법 Download PDFInfo
- Publication number
- KR20090017655A KR20090017655A KR1020087031950A KR20087031950A KR20090017655A KR 20090017655 A KR20090017655 A KR 20090017655A KR 1020087031950 A KR1020087031950 A KR 1020087031950A KR 20087031950 A KR20087031950 A KR 20087031950A KR 20090017655 A KR20090017655 A KR 20090017655A
- Authority
- KR
- South Korea
- Prior art keywords
- genes
- gene
- identified
- paragraphs
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000009169 immunotherapy Methods 0.000 title claims description 12
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 165
- 230000014509 gene expression Effects 0.000 claims abstract description 105
- 201000011510 cancer Diseases 0.000 claims abstract description 80
- 238000002493 microarray Methods 0.000 claims abstract description 48
- 238000009007 Diagnostic Kit Methods 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 1731
- 239000000523 sample Substances 0.000 claims description 276
- 238000000034 method Methods 0.000 claims description 140
- 239000000427 antigen Substances 0.000 claims description 99
- 102000036639 antigens Human genes 0.000 claims description 98
- 108091007433 antigens Proteins 0.000 claims description 98
- 239000002955 immunomodulating agent Substances 0.000 claims description 72
- 239000002671 adjuvant Substances 0.000 claims description 39
- 230000004044 response Effects 0.000 claims description 36
- 230000001024 immunotherapeutic effect Effects 0.000 claims description 34
- 239000003814 drug Substances 0.000 claims description 30
- 229940124597 therapeutic agent Drugs 0.000 claims description 25
- 230000028993 immune response Effects 0.000 claims description 21
- 238000004422 calculation algorithm Methods 0.000 claims description 15
- 230000001965 increasing effect Effects 0.000 claims description 15
- 230000003213 activating effect Effects 0.000 claims description 8
- 238000002619 cancer immunotherapy Methods 0.000 claims description 8
- 230000033228 biological regulation Effects 0.000 claims description 7
- 230000001939 inductive effect Effects 0.000 claims description 7
- 230000003827 upregulation Effects 0.000 claims description 7
- 230000009885 systemic effect Effects 0.000 claims description 6
- 108010050904 Interferons Proteins 0.000 claims description 5
- 102000014150 Interferons Human genes 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 5
- 229940079322 interferon Drugs 0.000 claims description 5
- 238000001959 radiotherapy Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 230000036039 immunity Effects 0.000 claims description 3
- 230000028709 inflammatory response Effects 0.000 claims description 2
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 42
- 150000007523 nucleic acids Chemical class 0.000 abstract description 13
- 102000039446 nucleic acids Human genes 0.000 abstract description 11
- 108020004707 nucleic acids Proteins 0.000 abstract description 11
- 238000002405 diagnostic procedure Methods 0.000 abstract description 3
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 119
- 108050008953 Melanoma-associated antigen Proteins 0.000 description 92
- 102000000440 Melanoma-associated antigen Human genes 0.000 description 90
- 238000012737 microarray-based gene expression Methods 0.000 description 85
- 238000012243 multiplex automated genomic engineering Methods 0.000 description 85
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 68
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 63
- 108091008874 T cell receptors Proteins 0.000 description 62
- 235000018102 proteins Nutrition 0.000 description 58
- 102000004169 proteins and genes Human genes 0.000 description 58
- 241000282414 Homo sapiens Species 0.000 description 52
- 239000013615 primer Substances 0.000 description 52
- 238000012360 testing method Methods 0.000 description 38
- 210000001744 T-lymphocyte Anatomy 0.000 description 36
- 108090000765 processed proteins & peptides Proteins 0.000 description 31
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 30
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 30
- 238000004458 analytical method Methods 0.000 description 27
- 238000012549 training Methods 0.000 description 27
- 108020001507 fusion proteins Proteins 0.000 description 25
- 102000037865 fusion proteins Human genes 0.000 description 25
- 201000001441 melanoma Diseases 0.000 description 24
- 108020004635 Complementary DNA Proteins 0.000 description 23
- 238000010804 cDNA synthesis Methods 0.000 description 23
- 101000658398 Homo sapiens T cell receptor beta variable 19 Proteins 0.000 description 22
- 230000004547 gene signature Effects 0.000 description 22
- 230000002441 reversible effect Effects 0.000 description 22
- 238000002255 vaccination Methods 0.000 description 22
- 239000002299 complementary DNA Substances 0.000 description 21
- 239000012634 fragment Substances 0.000 description 21
- 238000003753 real-time PCR Methods 0.000 description 21
- 108010015499 Protein Kinase C-theta Proteins 0.000 description 20
- 102100034884 T cell receptor beta variable 19 Human genes 0.000 description 20
- 239000000203 mixture Substances 0.000 description 20
- 101001014654 Homo sapiens Probable G-protein coupled receptor 171 Proteins 0.000 description 19
- 102100032555 Probable G-protein coupled receptor 171 Human genes 0.000 description 19
- 229940046168 CpG oligodeoxynucleotide Drugs 0.000 description 18
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 18
- 108091034117 Oligonucleotide Proteins 0.000 description 18
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 18
- 201000010099 disease Diseases 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 101000634846 Homo sapiens T-cell receptor-associated transmembrane adapter 1 Proteins 0.000 description 17
- 101000946863 Homo sapiens T-cell surface glycoprotein CD3 delta chain Proteins 0.000 description 17
- 102100029453 T-cell receptor-associated transmembrane adapter 1 Human genes 0.000 description 17
- 102100035891 T-cell surface glycoprotein CD3 delta chain Human genes 0.000 description 17
- 102100037932 Ubiquitin D Human genes 0.000 description 17
- 150000001413 amino acids Chemical group 0.000 description 17
- 108020004999 messenger RNA Proteins 0.000 description 17
- 102000005962 receptors Human genes 0.000 description 17
- 108020003175 receptors Proteins 0.000 description 17
- 102100025137 Early activation antigen CD69 Human genes 0.000 description 16
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 16
- 101000987581 Homo sapiens Perforin-1 Proteins 0.000 description 16
- 102100028467 Perforin-1 Human genes 0.000 description 16
- 102100027948 T cell receptor delta variable 2 Human genes 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 16
- 230000008569 process Effects 0.000 description 16
- 102000004196 processed proteins & peptides Human genes 0.000 description 16
- 108010065524 CD52 Antigen Proteins 0.000 description 15
- -1 Sulfate (Glucosamine) 3-O-Sulfate Chemical compound 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 15
- 238000009396 hybridization Methods 0.000 description 15
- 239000003446 ligand Substances 0.000 description 15
- 102100024217 CAMPATH-1 antigen Human genes 0.000 description 14
- 108091006027 G proteins Proteins 0.000 description 14
- 102000030782 GTP binding Human genes 0.000 description 14
- 108091000058 GTP-Binding Proteins 0.000 description 14
- 102100038395 Granzyme K Human genes 0.000 description 14
- 101001033007 Homo sapiens Granzyme K Proteins 0.000 description 14
- 101000649129 Homo sapiens T cell receptor delta variable 2 Proteins 0.000 description 14
- 101000662056 Homo sapiens Ubiquitin D Proteins 0.000 description 14
- 102100029450 M1-specific T cell receptor alpha chain Human genes 0.000 description 14
- 102100031225 Neuron navigator 1 Human genes 0.000 description 14
- 108010019992 STAT4 Transcription Factor Proteins 0.000 description 14
- 102000005886 STAT4 Transcription Factor Human genes 0.000 description 14
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 14
- 238000003556 assay Methods 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 102100032367 C-C motif chemokine 5 Human genes 0.000 description 13
- 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 description 13
- 102000001892 Protein Kinase C-theta Human genes 0.000 description 13
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 13
- 102100027581 Forkhead box protein P3 Human genes 0.000 description 12
- 102100030385 Granzyme B Human genes 0.000 description 12
- 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 description 12
- 101001009603 Homo sapiens Granzyme B Proteins 0.000 description 12
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 12
- 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 description 12
- 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 description 12
- 238000000692 Student's t-test Methods 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 229920001184 polypeptide Polymers 0.000 description 12
- 238000012353 t test Methods 0.000 description 12
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 12
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 11
- 102100021186 Granulysin Human genes 0.000 description 11
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 11
- 101001040751 Homo sapiens Granulysin Proteins 0.000 description 11
- 102100037850 Interferon gamma Human genes 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 10
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 10
- 230000003321 amplification Effects 0.000 description 10
- 230000004927 fusion Effects 0.000 description 10
- 230000002068 genetic effect Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 230000004083 survival effect Effects 0.000 description 10
- SSOORFWOBGFTHL-OTEJMHTDSA-N (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-carbamimidamido-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-oxopentanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SSOORFWOBGFTHL-OTEJMHTDSA-N 0.000 description 9
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 description 9
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 9
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 description 9
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 9
- 102100029452 T cell receptor alpha chain constant Human genes 0.000 description 9
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 description 9
- 239000012190 activator Substances 0.000 description 9
- 238000001574 biopsy Methods 0.000 description 9
- 230000002349 favourable effect Effects 0.000 description 9
- 230000003308 immunostimulating effect Effects 0.000 description 9
- 238000010606 normalization Methods 0.000 description 9
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 description 8
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 8
- 101001128969 Homo sapiens Neuron navigator 1 Proteins 0.000 description 8
- 101000713602 Homo sapiens T-box transcription factor TBX21 Proteins 0.000 description 8
- 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 8
- 102100036840 T-box transcription factor TBX21 Human genes 0.000 description 8
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 238000013528 artificial neural network Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 230000008595 infiltration Effects 0.000 description 8
- 238000001764 infiltration Methods 0.000 description 8
- 238000010208 microarray analysis Methods 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 210000004881 tumor cell Anatomy 0.000 description 8
- 102000004127 Cytokines Human genes 0.000 description 7
- 108090000695 Cytokines Proteins 0.000 description 7
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 7
- 101000598002 Homo sapiens Interferon regulatory factor 1 Proteins 0.000 description 7
- 101000634835 Homo sapiens M1-specific T cell receptor alpha chain Proteins 0.000 description 7
- 101000634836 Homo sapiens T cell receptor alpha chain MC.7.G5 Proteins 0.000 description 7
- 101000634853 Homo sapiens T cell receptor alpha chain constant Proteins 0.000 description 7
- 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 7
- 108060003951 Immunoglobulin Proteins 0.000 description 7
- 102100036981 Interferon regulatory factor 1 Human genes 0.000 description 7
- 102100039390 Toll-like receptor 7 Human genes 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000001900 immune effect Effects 0.000 description 7
- 102000018358 immunoglobulin Human genes 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 6
- 102100021411 C-terminal-binding protein 2 Human genes 0.000 description 6
- 102100039290 Gap junction gamma-1 protein Human genes 0.000 description 6
- 102100035688 Guanylate-binding protein 1 Human genes 0.000 description 6
- 102100036242 HLA class II histocompatibility antigen, DQ alpha 2 chain Human genes 0.000 description 6
- 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 6
- 101000980814 Homo sapiens CAMPATH-1 antigen Proteins 0.000 description 6
- 101001015004 Homo sapiens Integrin beta-3 Proteins 0.000 description 6
- 101000971400 Homo sapiens Protein kinase C eta type Proteins 0.000 description 6
- 101000662909 Homo sapiens T cell receptor beta constant 1 Proteins 0.000 description 6
- 101000679307 Homo sapiens T cell receptor gamma constant 2 Proteins 0.000 description 6
- 102100029572 Immunoglobulin kappa constant Human genes 0.000 description 6
- 102100032999 Integrin beta-3 Human genes 0.000 description 6
- 206010027476 Metastases Diseases 0.000 description 6
- 101710145285 Neuron navigator 1 Proteins 0.000 description 6
- 101150012011 PIANP gene Proteins 0.000 description 6
- 102100021556 Protein kinase C eta type Human genes 0.000 description 6
- 102100032891 Superoxide dismutase [Mn], mitochondrial Human genes 0.000 description 6
- 102100037272 T cell receptor beta constant 1 Human genes 0.000 description 6
- 102100022571 T cell receptor gamma constant 2 Human genes 0.000 description 6
- 238000003491 array Methods 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000002790 cross-validation Methods 0.000 description 6
- 229960001438 immunostimulant agent Drugs 0.000 description 6
- 239000003022 immunostimulating agent Substances 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 238000003046 intermediate neglect of differential overlap Methods 0.000 description 6
- 208000020816 lung neoplasm Diseases 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 239000013610 patient sample Substances 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 6
- 150000007949 saponins Chemical class 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 230000011664 signaling Effects 0.000 description 6
- 238000007619 statistical method Methods 0.000 description 6
- 108010045815 superoxide dismutase 2 Proteins 0.000 description 6
- 102000013135 CD52 Antigen Human genes 0.000 description 5
- 102100038542 Calcium homeostasis modulator protein 6 Human genes 0.000 description 5
- 102000014914 Carrier Proteins Human genes 0.000 description 5
- 102100035904 Caspase-1 Human genes 0.000 description 5
- 108010055166 Chemokine CCL5 Proteins 0.000 description 5
- 102000001327 Chemokine CCL5 Human genes 0.000 description 5
- 102100026234 Cytokine receptor common subunit gamma Human genes 0.000 description 5
- 102000001398 Granzyme Human genes 0.000 description 5
- 108060005986 Granzyme Proteins 0.000 description 5
- 108091059596 H3F3A Proteins 0.000 description 5
- 108010050568 HLA-DM antigens Proteins 0.000 description 5
- 108010086786 HLA-DQA1 antigen Proteins 0.000 description 5
- 102100039236 Histone H3.3 Human genes 0.000 description 5
- 101000741361 Homo sapiens Calcium homeostasis modulator protein 6 Proteins 0.000 description 5
- 101001055227 Homo sapiens Cytokine receptor common subunit gamma Proteins 0.000 description 5
- 101001046683 Homo sapiens Integrin alpha-L Proteins 0.000 description 5
- 101000956320 Homo sapiens Membrane-spanning 4-domains subfamily A member 6A Proteins 0.000 description 5
- 101001051767 Homo sapiens Protein kinase C beta type Proteins 0.000 description 5
- 101000658429 Homo sapiens T cell receptor beta variable 3-1 Proteins 0.000 description 5
- 102100022339 Integrin alpha-L Human genes 0.000 description 5
- 102000017095 Leukocyte Common Antigens Human genes 0.000 description 5
- 108010013709 Leukocyte Common Antigens Proteins 0.000 description 5
- 102100038555 Membrane-spanning 4-domains subfamily A member 6A Human genes 0.000 description 5
- 102100024923 Protein kinase C beta type Human genes 0.000 description 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 5
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 5
- 102100034887 T cell receptor beta variable 3-1 Human genes 0.000 description 5
- 208000024313 Testicular Neoplasms Diseases 0.000 description 5
- 206010057644 Testis cancer Diseases 0.000 description 5
- 108010060804 Toll-Like Receptor 4 Proteins 0.000 description 5
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 5
- 102100038183 Tyrosine-protein kinase SYK Human genes 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 239000012472 biological sample Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 230000001086 cytosolic effect Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 239000003623 enhancer Substances 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 239000002502 liposome Substances 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 210000003470 mitochondria Anatomy 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 239000002987 primer (paints) Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000013517 stratification Methods 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 201000003120 testicular cancer Diseases 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 102100034605 Atrial natriuretic peptide receptor 3 Human genes 0.000 description 4
- 102100022716 Atypical chemokine receptor 3 Human genes 0.000 description 4
- 102100027951 Brain and acute leukemia cytoplasmic protein Human genes 0.000 description 4
- 102100023702 C-C motif chemokine 13 Human genes 0.000 description 4
- 102100023701 C-C motif chemokine 18 Human genes 0.000 description 4
- 102100025250 C-X-C motif chemokine 14 Human genes 0.000 description 4
- 102100040840 C-type lectin domain family 7 member A Human genes 0.000 description 4
- 108010092574 CD69 antigen Proteins 0.000 description 4
- 102100030155 CDC42 small effector protein 2 Human genes 0.000 description 4
- 102100036167 CXXC-type zinc finger protein 5 Human genes 0.000 description 4
- 102000019034 Chemokines Human genes 0.000 description 4
- 108010012236 Chemokines Proteins 0.000 description 4
- 102100037799 DNA-binding protein Ikaros Human genes 0.000 description 4
- 102100024350 Dedicator of cytokinesis protein 8 Human genes 0.000 description 4
- 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 description 4
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 4
- 102100038595 Estrogen receptor Human genes 0.000 description 4
- 102100034554 Fanconi anemia group I protein Human genes 0.000 description 4
- 102100038647 Fibroleukin Human genes 0.000 description 4
- 102100026116 Follicular dendritic cell secreted peptide Human genes 0.000 description 4
- 102100024413 GTPase IMAP family member 5 Human genes 0.000 description 4
- 102100024421 GTPase IMAP family member 6 Human genes 0.000 description 4
- 102100031153 Growth arrest and DNA damage-inducible protein GADD45 beta Human genes 0.000 description 4
- 102100036241 HLA class II histocompatibility antigen, DQ beta 1 chain Human genes 0.000 description 4
- 108010065026 HLA-DQB1 antigen Proteins 0.000 description 4
- 101000780453 Homo sapiens All-trans-retinol dehydrogenase [NAD(+)] ADH1B Proteins 0.000 description 4
- 101000924488 Homo sapiens Atrial natriuretic peptide receptor 3 Proteins 0.000 description 4
- 101000678890 Homo sapiens Atypical chemokine receptor 3 Proteins 0.000 description 4
- 101000697853 Homo sapiens Brain and acute leukemia cytoplasmic protein Proteins 0.000 description 4
- 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 4
- 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 4
- 101000858068 Homo sapiens C-X-C motif chemokine 14 Proteins 0.000 description 4
- 101000749325 Homo sapiens C-type lectin domain family 7 member A Proteins 0.000 description 4
- 101000794294 Homo sapiens CDC42 small effector protein 2 Proteins 0.000 description 4
- 101000947154 Homo sapiens CXXC-type zinc finger protein 5 Proteins 0.000 description 4
- 101000715398 Homo sapiens Caspase-1 Proteins 0.000 description 4
- 101000599038 Homo sapiens DNA-binding protein Ikaros Proteins 0.000 description 4
- 101001052946 Homo sapiens Dedicator of cytokinesis protein 8 Proteins 0.000 description 4
- 101000848174 Homo sapiens Fanconi anemia group I protein Proteins 0.000 description 4
- 101001031613 Homo sapiens Fibroleukin Proteins 0.000 description 4
- 101000912993 Homo sapiens Follicular dendritic cell secreted peptide Proteins 0.000 description 4
- 101000833376 Homo sapiens GTPase IMAP family member 5 Proteins 0.000 description 4
- 101000833389 Homo sapiens GTPase IMAP family member 6 Proteins 0.000 description 4
- 101000746078 Homo sapiens Gap junction gamma-1 protein Proteins 0.000 description 4
- 101001066164 Homo sapiens Growth arrest and DNA damage-inducible protein GADD45 beta Proteins 0.000 description 4
- 101001001336 Homo sapiens Guanylate-binding protein 1 Proteins 0.000 description 4
- 101000840257 Homo sapiens Immunoglobulin kappa constant Proteins 0.000 description 4
- 101001076418 Homo sapiens Interleukin-1 receptor type 1 Proteins 0.000 description 4
- 101000780205 Homo sapiens Long-chain-fatty-acid-CoA ligase 5 Proteins 0.000 description 4
- 101001055091 Homo sapiens Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 4
- 101000735223 Homo sapiens Palmdelphin Proteins 0.000 description 4
- 101000911753 Homo sapiens Protein FAM107B Proteins 0.000 description 4
- 101000835300 Homo sapiens Protein THEMIS Proteins 0.000 description 4
- 101000735368 Homo sapiens Protocadherin-9 Proteins 0.000 description 4
- 101001100309 Homo sapiens RNA-binding protein 47 Proteins 0.000 description 4
- 101001060852 Homo sapiens Ras-related protein Rab-34 Proteins 0.000 description 4
- 101001128094 Homo sapiens Ras-related protein Rab-34, isoform NARR Proteins 0.000 description 4
- 101000581151 Homo sapiens Rho GTPase-activating protein 9 Proteins 0.000 description 4
- 101000738413 Homo sapiens T-cell surface glycoprotein CD3 gamma chain Proteins 0.000 description 4
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 4
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 4
- 101000649120 Homo sapiens Translocating chain-associated membrane protein 2 Proteins 0.000 description 4
- 101000835634 Homo sapiens Tubulin-folding cofactor B Proteins 0.000 description 4
- 101000800807 Homo sapiens Tumor necrosis factor alpha-induced protein 8 Proteins 0.000 description 4
- 101000830565 Homo sapiens Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 description 4
- 101000801227 Homo sapiens Tumor necrosis factor receptor superfamily member 19 Proteins 0.000 description 4
- 102100026016 Interleukin-1 receptor type 1 Human genes 0.000 description 4
- 102100034318 Long-chain-fatty-acid-CoA ligase 5 Human genes 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 108010052285 Membrane Proteins Proteins 0.000 description 4
- 102100026907 Mitogen-activated protein kinase kinase kinase 8 Human genes 0.000 description 4
- 101100233255 Mus musculus Ipp gene Proteins 0.000 description 4
- 101100513472 Mus musculus Minpp1 gene Proteins 0.000 description 4
- GUVMFDICMFQHSZ-UHFFFAOYSA-N N-(1-aminoethenyl)-1-[4-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[hydroxy-[[3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(4-amino-2-oxopyrimidin-1-yl)-2-[[hydroxy-[2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylimidazole-4-carboxamide Chemical compound CC1=C(C(=O)NC(N)=C)N=CN1C1OC(COP(O)(=S)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=S)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)CO)C(OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)O)C1 GUVMFDICMFQHSZ-UHFFFAOYSA-N 0.000 description 4
- 108700020796 Oncogene Proteins 0.000 description 4
- 102100035005 Palmdelphin Human genes 0.000 description 4
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 4
- 101710188053 Protein D Proteins 0.000 description 4
- 102100026983 Protein FAM107B Human genes 0.000 description 4
- 102100026111 Protein THEMIS Human genes 0.000 description 4
- 102100034957 Protocadherin-9 Human genes 0.000 description 4
- 102100038822 RNA-binding protein 47 Human genes 0.000 description 4
- 102100031921 Ras-related protein Rab-34, isoform NARR Human genes 0.000 description 4
- 101710132893 Resolvase Proteins 0.000 description 4
- 102100027658 Rho GTPase-activating protein 9 Human genes 0.000 description 4
- 102100029198 SLAM family member 7 Human genes 0.000 description 4
- 108091006976 SLC40A1 Proteins 0.000 description 4
- 102100032008 Solute carrier family 40 member 1 Human genes 0.000 description 4
- 102100029488 T cell receptor alpha variable 20 Human genes 0.000 description 4
- 102100037911 T-cell surface glycoprotein CD3 gamma chain Human genes 0.000 description 4
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 4
- 102000008235 Toll-Like Receptor 9 Human genes 0.000 description 4
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 4
- 102100024324 Toll-like receptor 3 Human genes 0.000 description 4
- 102100027957 Translocating chain-associated membrane protein 2 Human genes 0.000 description 4
- 102100026482 Tubulin-folding cofactor B Human genes 0.000 description 4
- 102100024596 Tumor necrosis factor alpha-induced protein 3 Human genes 0.000 description 4
- 102100033649 Tumor necrosis factor alpha-induced protein 8 Human genes 0.000 description 4
- 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 4
- 102100033760 Tumor necrosis factor receptor superfamily member 19 Human genes 0.000 description 4
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 4
- 108091008324 binding proteins Proteins 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 239000013256 coordination polymer Substances 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 229940127089 cytotoxic agent Drugs 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 102000011778 gamma-delta T-Cell Antigen Receptors Human genes 0.000 description 4
- 108010062214 gamma-delta T-Cell Antigen Receptors Proteins 0.000 description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 238000003364 immunohistochemistry Methods 0.000 description 4
- PNDZEEPOYCVIIY-UHFFFAOYSA-N indo-1 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C=2N=C3[CH]C(=CC=C3C=2)C(O)=O)N(CC(O)=O)CC(O)=O)=C1 PNDZEEPOYCVIIY-UHFFFAOYSA-N 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 108010047926 leucyl-lysyl-tyrosine Proteins 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 201000005202 lung cancer Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000009401 metastasis Effects 0.000 description 4
- 229940035032 monophosphoryl lipid a Drugs 0.000 description 4
- 239000007764 o/w emulsion Substances 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 238000000513 principal component analysis Methods 0.000 description 4
- 238000004393 prognosis Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 210000001550 testis Anatomy 0.000 description 4
- 230000004614 tumor growth Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102100040121 Allograft inflammatory factor 1 Human genes 0.000 description 3
- 101710145634 Antigen 1 Proteins 0.000 description 3
- 102100033648 Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 Human genes 0.000 description 3
- 102100022983 B-cell lymphoma/leukemia 11B Human genes 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 102100023705 C-C motif chemokine 14 Human genes 0.000 description 3
- 102100022529 Cadherin-19 Human genes 0.000 description 3
- 101100315624 Caenorhabditis elegans tyr-1 gene Proteins 0.000 description 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 3
- 108010008978 Chemokine CXCL10 Proteins 0.000 description 3
- 102100034951 Coiled-coil domain-containing protein 69 Human genes 0.000 description 3
- 102100030977 Collagen alpha-3(IX) chain Human genes 0.000 description 3
- 102100028183 Cytohesin-interacting protein Human genes 0.000 description 3
- 102100024417 GTPase IMAP family member 2 Human genes 0.000 description 3
- 108010001496 Galectin 2 Proteins 0.000 description 3
- 102100030386 Granzyme A Human genes 0.000 description 3
- 102100023911 Growth factor receptor-bound protein 14 Human genes 0.000 description 3
- 102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 description 3
- 102100033079 HLA class II histocompatibility antigen, DM alpha chain Human genes 0.000 description 3
- 102100029966 HLA class II histocompatibility antigen, DP alpha 1 chain Human genes 0.000 description 3
- 102100040505 HLA class II histocompatibility antigen, DR alpha chain Human genes 0.000 description 3
- 102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 description 3
- 108010093061 HLA-DPA1 antigen Proteins 0.000 description 3
- 108010067802 HLA-DR alpha-Chains Proteins 0.000 description 3
- 108010039343 HLA-DRB1 Chains Proteins 0.000 description 3
- 101000890626 Homo sapiens Allograft inflammatory factor 1 Proteins 0.000 description 3
- 101000733571 Homo sapiens Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 Proteins 0.000 description 3
- 101000903697 Homo sapiens B-cell lymphoma/leukemia 11B Proteins 0.000 description 3
- 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 3
- 101000899410 Homo sapiens Cadherin-19 Proteins 0.000 description 3
- 101000946601 Homo sapiens Coiled-coil domain-containing protein 69 Proteins 0.000 description 3
- 101000919644 Homo sapiens Collagen alpha-3(IX) chain Proteins 0.000 description 3
- 101000916686 Homo sapiens Cytohesin-interacting protein Proteins 0.000 description 3
- 101000833381 Homo sapiens GTPase IMAP family member 2 Proteins 0.000 description 3
- 101001009599 Homo sapiens Granzyme A Proteins 0.000 description 3
- 101000904875 Homo sapiens Growth factor receptor-bound protein 14 Proteins 0.000 description 3
- 101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 description 3
- 101000840271 Homo sapiens Immunoglobulin lambda constant 2 Proteins 0.000 description 3
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 3
- 101000994378 Homo sapiens Integrin alpha-3 Proteins 0.000 description 3
- 101000980823 Homo sapiens Leukocyte surface antigen CD53 Proteins 0.000 description 3
- 101001065658 Homo sapiens Leukocyte-specific transcript 1 protein Proteins 0.000 description 3
- 101001051291 Homo sapiens Lysosomal-associated transmembrane protein 5 Proteins 0.000 description 3
- 101001112224 Homo sapiens Neutrophil cytosol factor 2 Proteins 0.000 description 3
- 101001072081 Homo sapiens Proprotein convertase subtilisin/kexin type 5 Proteins 0.000 description 3
- 101001092917 Homo sapiens SAM domain-containing protein SAMSN-1 Proteins 0.000 description 3
- 101000825432 Homo sapiens SHC-transforming protein 4 Proteins 0.000 description 3
- 101000680681 Homo sapiens T cell receptor gamma variable 9 Proteins 0.000 description 3
- 101000891084 Homo sapiens T-cell activation Rho GTPase-activating protein Proteins 0.000 description 3
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 3
- 102100029620 Immunoglobulin lambda constant 2 Human genes 0.000 description 3
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 3
- 102100032819 Integrin alpha-3 Human genes 0.000 description 3
- 102100024221 Leukocyte surface antigen CD53 Human genes 0.000 description 3
- 102100032012 Leukocyte-specific transcript 1 protein Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 102100024625 Lysosomal-associated transmembrane protein 5 Human genes 0.000 description 3
- 206010027480 Metastatic malignant melanoma Diseases 0.000 description 3
- 108090001040 Microtubule-associated protein 1B Proteins 0.000 description 3
- 102000004866 Microtubule-associated protein 1B Human genes 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 101100273286 Mus musculus Casp4 gene Proteins 0.000 description 3
- 102100023618 Neutrophil cytosol factor 2 Human genes 0.000 description 3
- 238000000636 Northern blotting Methods 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 3
- 238000010222 PCR analysis Methods 0.000 description 3
- 108091093018 PVT1 Proteins 0.000 description 3
- 238000010240 RT-PCR analysis Methods 0.000 description 3
- 102100036195 SAM domain-containing protein SAMSN-1 Human genes 0.000 description 3
- 102100022333 SHC-transforming protein 4 Human genes 0.000 description 3
- 102100032776 Semaphorin-4F Human genes 0.000 description 3
- 102100039753 T cell receptor beta variable 5-4 Human genes 0.000 description 3
- 102100022393 T cell receptor gamma variable 9 Human genes 0.000 description 3
- 102100040346 T-cell activation Rho GTPase-activating protein Human genes 0.000 description 3
- 102100033663 Transforming growth factor beta receptor type 3 Human genes 0.000 description 3
- 101710138219 Ubiquitin D Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000012830 cancer therapeutic Substances 0.000 description 3
- 231100000357 carcinogen Toxicity 0.000 description 3
- 239000003183 carcinogenic agent Substances 0.000 description 3
- 101150052649 ctbp2 gene Proteins 0.000 description 3
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 201000005619 esophageal carcinoma Diseases 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 3
- 230000002163 immunogen Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000007477 logistic regression Methods 0.000 description 3
- 238000010801 machine learning Methods 0.000 description 3
- 208000021039 metastatic melanoma Diseases 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 238000002966 oligonucleotide array Methods 0.000 description 3
- 238000011275 oncology therapy Methods 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 208000002491 severe combined immunodeficiency Diseases 0.000 description 3
- 230000019491 signal transduction Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 229940044655 toll-like receptor 9 agonist Drugs 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 101150084750 1 gene Proteins 0.000 description 2
- 102100035905 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 Human genes 0.000 description 2
- 102100026210 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 Human genes 0.000 description 2
- JVICQEYUDFKRNP-UHFFFAOYSA-N 1h-indol-2-amine;1h-pyrrole Chemical compound C=1C=CNC=1.C1=CC=C2NC(N)=CC2=C1 JVICQEYUDFKRNP-UHFFFAOYSA-N 0.000 description 2
- 102100034510 2-phosphoxylose phosphatase 1 Human genes 0.000 description 2
- 102100026007 ADAM DEC1 Human genes 0.000 description 2
- 102100022886 ADP-ribosylation factor-like protein 4C Human genes 0.000 description 2
- 102100032898 AMP deaminase 3 Human genes 0.000 description 2
- 102100033347 AP-2 complex subunit beta Human genes 0.000 description 2
- 102100027782 ATP synthase-coupling factor 6, mitochondrial Human genes 0.000 description 2
- 206010000830 Acute leukaemia Diseases 0.000 description 2
- 102100025976 Adenosine deaminase 2 Human genes 0.000 description 2
- 102100032158 Adenylate cyclase type 6 Human genes 0.000 description 2
- 102100032152 Adenylate cyclase type 7 Human genes 0.000 description 2
- YEELWQSXYBJVSV-UWJYBYFXSA-N Ala-Cys-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YEELWQSXYBJVSV-UWJYBYFXSA-N 0.000 description 2
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 102100033816 Aldehyde dehydrogenase, mitochondrial Human genes 0.000 description 2
- 108700023418 Amidases Proteins 0.000 description 2
- 102100033830 Amphiphysin Human genes 0.000 description 2
- 102100032040 Amphoterin-induced protein 2 Human genes 0.000 description 2
- 102100025665 Angiopoietin-related protein 1 Human genes 0.000 description 2
- 102100034290 Ankyrin repeat domain-containing protein 22 Human genes 0.000 description 2
- 102100036817 Ankyrin-3 Human genes 0.000 description 2
- 102100030346 Antigen peptide transporter 1 Human genes 0.000 description 2
- 102100030766 Apolipoprotein L3 Human genes 0.000 description 2
- 102100033653 Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 Human genes 0.000 description 2
- 102100026291 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 Human genes 0.000 description 2
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 2
- 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 2
- 102000040350 B family Human genes 0.000 description 2
- 108091072128 B family Proteins 0.000 description 2
- 102100035634 B-cell linker protein Human genes 0.000 description 2
- 102100027314 Beta-2-microglobulin Human genes 0.000 description 2
- 102100026031 Beta-glucuronidase Human genes 0.000 description 2
- 102100028252 Brain acid soluble protein 1 Human genes 0.000 description 2
- 102100031151 C-C chemokine receptor type 2 Human genes 0.000 description 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 2
- 102100024936 CBY1-interacting BAR domain-containing protein 1 Human genes 0.000 description 2
- 108010017009 CD11b Antigen Proteins 0.000 description 2
- 102100021992 CD209 antigen Human genes 0.000 description 2
- 102100038078 CD276 antigen Human genes 0.000 description 2
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 2
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 2
- 102100036008 CD48 antigen Human genes 0.000 description 2
- 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 2
- 102100039372 Calcium uniporter regulatory subunit MCUb, mitochondrial Human genes 0.000 description 2
- 102100026252 Calcium/calmodulin-dependent protein kinase II inhibitor 1 Human genes 0.000 description 2
- 102100025593 Calmodulin-regulated spectrin-associated protein 2 Human genes 0.000 description 2
- 101001110283 Canis lupus familiaris Ras-related C3 botulinum toxin substrate 1 Proteins 0.000 description 2
- 102100038710 Capping protein-inhibiting regulator of actin dynamics Human genes 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 102100035654 Cathepsin S Human genes 0.000 description 2
- 102100026658 Cathepsin W Human genes 0.000 description 2
- 102100023321 Ceruloplasmin Human genes 0.000 description 2
- 102000006579 Chemokine CXCL10 Human genes 0.000 description 2
- 108010008980 Chemokine CXCL11 Proteins 0.000 description 2
- 102000006577 Chemokine CXCL11 Human genes 0.000 description 2
- 241001227713 Chiron Species 0.000 description 2
- 102100031065 Choline kinase alpha Human genes 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 102100028233 Coronin-1A Human genes 0.000 description 2
- 102100021507 Costars family protein ABRACL Human genes 0.000 description 2
- 102100035353 Cyclin-dependent kinase 2-associated protein 1 Human genes 0.000 description 2
- 102100032756 Cysteine-rich protein 1 Human genes 0.000 description 2
- 102100031655 Cytochrome b5 Human genes 0.000 description 2
- 102100039061 Cytokine receptor common subunit beta Human genes 0.000 description 2
- 102100025282 DENN domain-containing protein 2D Human genes 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 230000005778 DNA damage Effects 0.000 description 2
- 231100000277 DNA damage Toxicity 0.000 description 2
- 102100031230 DNA topoisomerase I, mitochondrial Human genes 0.000 description 2
- OAUWKHSGCCPXOD-UHFFFAOYSA-N DOC1 Natural products C1=CC(O)=C2C(CC(=O)NCCCCCNCCCNCCCNCCCN)=CNC2=C1 OAUWKHSGCCPXOD-UHFFFAOYSA-N 0.000 description 2
- 102100024353 Dedicator of cytokinesis protein 9 Human genes 0.000 description 2
- 102100029790 Defensin-6 Human genes 0.000 description 2
- 102100036504 Dehydrogenase/reductase SDR family member 9 Human genes 0.000 description 2
- 102100040606 Dermatan-sulfate epimerase Human genes 0.000 description 2
- 108010086291 Deubiquitinating Enzyme CYLD Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102100029921 Dipeptidyl peptidase 1 Human genes 0.000 description 2
- 102100031250 Disks large-associated protein 1 Human genes 0.000 description 2
- 102100037730 Dynein regulatory complex protein 8 Human genes 0.000 description 2
- 102100029641 E3 ubiquitin-protein ligase DTX4 Human genes 0.000 description 2
- 102100031539 E3 ubiquitin-protein ligase RNF144B Human genes 0.000 description 2
- 102100031785 Endothelial transcription factor GATA-2 Human genes 0.000 description 2
- 102100032029 Epidermal growth factor-like protein 6 Human genes 0.000 description 2
- 102100035976 Exostosin-like 3 Human genes 0.000 description 2
- 102100038003 F-box only protein 16 Human genes 0.000 description 2
- 102100035261 FYN-binding protein 1 Human genes 0.000 description 2
- 102100038636 FYVE, RhoGEF and PH domain-containing protein 2 Human genes 0.000 description 2
- 102100032790 Flotillin-1 Human genes 0.000 description 2
- 102100030334 Friend leukemia integration 1 transcription factor Human genes 0.000 description 2
- 102100021245 G-protein coupled receptor 183 Human genes 0.000 description 2
- 101710101406 G-protein coupled receptor 183 Proteins 0.000 description 2
- 102100023940 G-protein-signaling modulator 1 Human genes 0.000 description 2
- 102100024185 G1/S-specific cyclin-D2 Human genes 0.000 description 2
- 102100033423 GDNF family receptor alpha-1 Human genes 0.000 description 2
- 102100027346 GTP cyclohydrolase 1 Human genes 0.000 description 2
- 102100024412 GTPase IMAP family member 4 Human genes 0.000 description 2
- 102100024422 GTPase IMAP family member 7 Human genes 0.000 description 2
- 102100024418 GTPase IMAP family member 8 Human genes 0.000 description 2
- 102100021735 Galectin-2 Human genes 0.000 description 2
- 102100041007 Glia maturation factor gamma Human genes 0.000 description 2
- 102100039632 Glioma pathogenesis-related protein 1 Human genes 0.000 description 2
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 2
- QNJNPKSWAHPYGI-JYJNAYRXSA-N Glu-Phe-Leu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 QNJNPKSWAHPYGI-JYJNAYRXSA-N 0.000 description 2
- YPHPEHMXOYTEQG-LAEOZQHASA-N Glu-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O YPHPEHMXOYTEQG-LAEOZQHASA-N 0.000 description 2
- JYPCXBJRLBHWME-IUCAKERBSA-N Gly-Pro-Arg Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JYPCXBJRLBHWME-IUCAKERBSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010018691 Granuloma Diseases 0.000 description 2
- 101710110781 Guanylate-binding protein 1 Proteins 0.000 description 2
- 102100028538 Guanylate-binding protein 4 Human genes 0.000 description 2
- 102100028539 Guanylate-binding protein 5 Human genes 0.000 description 2
- 102100021514 HLA class I histocompatibility antigen protein P5 Human genes 0.000 description 2
- 102100031258 HLA class II histocompatibility antigen, DM beta chain Human genes 0.000 description 2
- 102100031618 HLA class II histocompatibility antigen, DP beta 1 chain Human genes 0.000 description 2
- 102100028636 HLA class II histocompatibility antigen, DR beta 4 chain Human genes 0.000 description 2
- 102100028640 HLA class II histocompatibility antigen, DR beta 5 chain Human genes 0.000 description 2
- 108010045483 HLA-DPB1 antigen Proteins 0.000 description 2
- 108010040960 HLA-DRB4 Chains Proteins 0.000 description 2
- 108010016996 HLA-DRB5 Chains Proteins 0.000 description 2
- 102100027385 Hematopoietic lineage cell-specific protein Human genes 0.000 description 2
- 102100028006 Heme oxygenase 1 Human genes 0.000 description 2
- 102100023926 Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 Human genes 0.000 description 2
- 102100028716 Hermansky-Pudlak syndrome 3 protein Human genes 0.000 description 2
- KHUFDBQXGLEIHC-BZSNNMDCSA-N His-Leu-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 KHUFDBQXGLEIHC-BZSNNMDCSA-N 0.000 description 2
- 102100025061 Homeobox protein Hox-B7 Human genes 0.000 description 2
- 102100040615 Homeobox protein MSX-2 Human genes 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000929840 Homo sapiens 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 Proteins 0.000 description 2
- 101000691589 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 Proteins 0.000 description 2
- 101001132150 Homo sapiens 2-phosphoxylose phosphatase 1 Proteins 0.000 description 2
- 101000719904 Homo sapiens ADAM DEC1 Proteins 0.000 description 2
- 101000974390 Homo sapiens ADP-ribosylation factor-like protein 4C Proteins 0.000 description 2
- 101000797462 Homo sapiens AMP deaminase 3 Proteins 0.000 description 2
- 101000732341 Homo sapiens AP-2 complex subunit beta Proteins 0.000 description 2
- 101000936965 Homo sapiens ATP synthase-coupling factor 6, mitochondrial Proteins 0.000 description 2
- 101000720051 Homo sapiens Adenosine deaminase 2 Proteins 0.000 description 2
- 101000775483 Homo sapiens Adenylate cyclase type 7 Proteins 0.000 description 2
- 101000779845 Homo sapiens Amphiphysin Proteins 0.000 description 2
- 101000776165 Homo sapiens Amphoterin-induced protein 2 Proteins 0.000 description 2
- 101000779315 Homo sapiens Anaphase-promoting complex subunit 10 Proteins 0.000 description 2
- 101000693093 Homo sapiens Angiopoietin-related protein 1 Proteins 0.000 description 2
- 101000780100 Homo sapiens Ankyrin repeat domain-containing protein 22 Proteins 0.000 description 2
- 101000928342 Homo sapiens Ankyrin-3 Proteins 0.000 description 2
- 101000793443 Homo sapiens Apolipoprotein L3 Proteins 0.000 description 2
- 101000733557 Homo sapiens Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 Proteins 0.000 description 2
- 101000785915 Homo sapiens Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 Proteins 0.000 description 2
- 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 2
- 101000803266 Homo sapiens B-cell linker protein Proteins 0.000 description 2
- 101000959437 Homo sapiens Beta-2 adrenergic receptor Proteins 0.000 description 2
- 101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 description 2
- 101000935689 Homo sapiens Brain acid soluble protein 1 Proteins 0.000 description 2
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 2
- 101000761497 Homo sapiens CBY1-interacting BAR domain-containing protein 1 Proteins 0.000 description 2
- 101000716130 Homo sapiens CD48 antigen Proteins 0.000 description 2
- 101000961406 Homo sapiens Calcium uniporter regulatory subunit MCUb, mitochondrial Proteins 0.000 description 2
- 101000913913 Homo sapiens Calcium/calmodulin-dependent protein kinase II inhibitor 1 Proteins 0.000 description 2
- 101000932961 Homo sapiens Calmodulin-regulated spectrin-associated protein 2 Proteins 0.000 description 2
- 101000957909 Homo sapiens Capping protein-inhibiting regulator of actin dynamics Proteins 0.000 description 2
- 101000910988 Homo sapiens Cathepsin W Proteins 0.000 description 2
- 101000908019 Homo sapiens Ceruloplasmin Proteins 0.000 description 2
- 101000777314 Homo sapiens Choline kinase alpha Proteins 0.000 description 2
- 101000860852 Homo sapiens Coronin-1A Proteins 0.000 description 2
- 101000677808 Homo sapiens Costars family protein ABRACL Proteins 0.000 description 2
- 101000737813 Homo sapiens Cyclin-dependent kinase 2-associated protein 1 Proteins 0.000 description 2
- 101000942084 Homo sapiens Cysteine-rich protein 1 Proteins 0.000 description 2
- 101000922386 Homo sapiens Cytochrome b5 Proteins 0.000 description 2
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 description 2
- 101000722280 Homo sapiens DENN domain-containing protein 2D Proteins 0.000 description 2
- 101001052948 Homo sapiens Dedicator of cytokinesis protein 9 Proteins 0.000 description 2
- 101000865479 Homo sapiens Defensin-6 Proteins 0.000 description 2
- 101000928746 Homo sapiens Dehydrogenase/reductase SDR family member 9 Proteins 0.000 description 2
- 101000816698 Homo sapiens Dermatan-sulfate epimerase Proteins 0.000 description 2
- 101000830440 Homo sapiens Differentially expressed in FDCP 6 homolog Proteins 0.000 description 2
- 101000793922 Homo sapiens Dipeptidyl peptidase 1 Proteins 0.000 description 2
- 101000844784 Homo sapiens Disks large-associated protein 1 Proteins 0.000 description 2
- 101000880830 Homo sapiens Dynein regulatory complex protein 8 Proteins 0.000 description 2
- 101000865806 Homo sapiens E3 ubiquitin-protein ligase DTX4 Proteins 0.000 description 2
- 101001130266 Homo sapiens E3 ubiquitin-protein ligase RNF144B Proteins 0.000 description 2
- 101001066265 Homo sapiens Endothelial transcription factor GATA-2 Proteins 0.000 description 2
- 101000921196 Homo sapiens Epidermal growth factor-like protein 6 Proteins 0.000 description 2
- 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 description 2
- 101000875556 Homo sapiens Exostosin-like 3 Proteins 0.000 description 2
- 101000878641 Homo sapiens F-box only protein 16 Proteins 0.000 description 2
- 101001022163 Homo sapiens FYN-binding protein 1 Proteins 0.000 description 2
- 101001031749 Homo sapiens FYVE, RhoGEF and PH domain-containing protein 2 Proteins 0.000 description 2
- 101000847538 Homo sapiens Flotillin-1 Proteins 0.000 description 2
- 101001062996 Homo sapiens Friend leukemia integration 1 transcription factor Proteins 0.000 description 2
- 101000904748 Homo sapiens G-protein-signaling modulator 1 Proteins 0.000 description 2
- 101000980741 Homo sapiens G1/S-specific cyclin-D2 Proteins 0.000 description 2
- 101000997961 Homo sapiens GDNF family receptor alpha-1 Proteins 0.000 description 2
- 101000862581 Homo sapiens GTP cyclohydrolase 1 Proteins 0.000 description 2
- 101000833375 Homo sapiens GTPase IMAP family member 4 Proteins 0.000 description 2
- 101000833390 Homo sapiens GTPase IMAP family member 7 Proteins 0.000 description 2
- 101000833386 Homo sapiens GTPase IMAP family member 8 Proteins 0.000 description 2
- 101001039458 Homo sapiens Glia maturation factor gamma Proteins 0.000 description 2
- 101000888759 Homo sapiens Glioma pathogenesis-related protein 1 Proteins 0.000 description 2
- 101001058851 Homo sapiens Guanylate-binding protein 4 Proteins 0.000 description 2
- 101001058850 Homo sapiens Guanylate-binding protein 5 Proteins 0.000 description 2
- 101000899151 Homo sapiens HLA class I histocompatibility antigen protein P5 Proteins 0.000 description 2
- 101001009091 Homo sapiens Hematopoietic lineage cell-specific protein Proteins 0.000 description 2
- 101001079623 Homo sapiens Heme oxygenase 1 Proteins 0.000 description 2
- 101001048112 Homo sapiens Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 Proteins 0.000 description 2
- 101000985492 Homo sapiens Hermansky-Pudlak syndrome 3 protein Proteins 0.000 description 2
- 101001077539 Homo sapiens Homeobox protein Hox-B7 Proteins 0.000 description 2
- 101000967222 Homo sapiens Homeobox protein MSX-2 Proteins 0.000 description 2
- 101000840273 Homo sapiens Immunoglobulin lambda constant 1 Proteins 0.000 description 2
- 101001005336 Homo sapiens Immunoglobulin lambda variable 3-25 Proteins 0.000 description 2
- 101000852613 Homo sapiens Importin-11 Proteins 0.000 description 2
- 101000856513 Homo sapiens Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Proteins 0.000 description 2
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 2
- 101001032345 Homo sapiens Interferon regulatory factor 8 Proteins 0.000 description 2
- 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 2
- 101001076422 Homo sapiens Interleukin-1 receptor type 2 Proteins 0.000 description 2
- 101001083151 Homo sapiens Interleukin-10 receptor subunit alpha Proteins 0.000 description 2
- 101000994195 Homo sapiens Isochorismatase domain-containing protein 1 Proteins 0.000 description 2
- 101001050320 Homo sapiens Junctional adhesion molecule B Proteins 0.000 description 2
- 101001050318 Homo sapiens Junctional adhesion molecule-like Proteins 0.000 description 2
- 101001049181 Homo sapiens Killer cell lectin-like receptor subfamily B member 1 Proteins 0.000 description 2
- 101001027634 Homo sapiens Kinesin-like protein KIF21B Proteins 0.000 description 2
- 101000984626 Homo sapiens Low-density lipoprotein receptor-related protein 12 Proteins 0.000 description 2
- 101000604998 Homo sapiens Lysosome-associated membrane glycoprotein 3 Proteins 0.000 description 2
- 101000969688 Homo sapiens Macrophage-expressed gene 1 protein Proteins 0.000 description 2
- 101000958390 Homo sapiens Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA Proteins 0.000 description 2
- 101000694615 Homo sapiens Membrane primary amine oxidase Proteins 0.000 description 2
- 101000956317 Homo sapiens Membrane-spanning 4-domains subfamily A member 4A Proteins 0.000 description 2
- 101001014567 Homo sapiens Membrane-spanning 4-domains subfamily A member 7 Proteins 0.000 description 2
- 101000947699 Homo sapiens Microfibril-associated glycoprotein 4 Proteins 0.000 description 2
- 101001132833 Homo sapiens Mitochondrial ribosome-associated GTPase 2 Proteins 0.000 description 2
- 101001059984 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 4 Proteins 0.000 description 2
- 101000655467 Homo sapiens Multidrug and toxin extrusion protein 1 Proteins 0.000 description 2
- 101001000104 Homo sapiens Myosin-11 Proteins 0.000 description 2
- 101000961071 Homo sapiens NF-kappa-B inhibitor alpha Proteins 0.000 description 2
- 101000995138 Homo sapiens NFAT activation molecule 1 Proteins 0.000 description 2
- 101000979575 Homo sapiens NLR family CARD domain-containing protein 3 Proteins 0.000 description 2
- 101001024704 Homo sapiens Nck-associated protein 1-like Proteins 0.000 description 2
- 101000972834 Homo sapiens Normal mucosa of esophagus-specific gene 1 protein Proteins 0.000 description 2
- 101000974005 Homo sapiens Nucleosome assembly protein 1-like 2 Proteins 0.000 description 2
- 101001086545 Homo sapiens Olfactomedin-like protein 1 Proteins 0.000 description 2
- 101001137504 Homo sapiens Outer dynein arm-docking complex subunit 4 Proteins 0.000 description 2
- 101001120082 Homo sapiens P2Y purinoceptor 13 Proteins 0.000 description 2
- 101001121539 Homo sapiens P2Y purinoceptor 14 Proteins 0.000 description 2
- 101000609957 Homo sapiens PTB-containing, cubilin and LRP1-interacting protein Proteins 0.000 description 2
- 101000854777 Homo sapiens Pantetheinase Proteins 0.000 description 2
- 101000891014 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP14 Proteins 0.000 description 2
- 101001073216 Homo sapiens Period circadian protein homolog 2 Proteins 0.000 description 2
- 101001072881 Homo sapiens Phosphoglucomutase-like protein 5 Proteins 0.000 description 2
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 2
- 101000935642 Homo sapiens Phosphoinositide 3-kinase adapter protein 1 Proteins 0.000 description 2
- 101000609532 Homo sapiens Phosphoinositide-3-kinase-interacting protein 1 Proteins 0.000 description 2
- 101000595918 Homo sapiens Phospholipase A and acyltransferase 4 Proteins 0.000 description 2
- 101000596046 Homo sapiens Plastin-2 Proteins 0.000 description 2
- 101001116302 Homo sapiens Platelet endothelial cell adhesion molecule Proteins 0.000 description 2
- 101000692464 Homo sapiens Platelet-derived growth factor receptor-like protein Proteins 0.000 description 2
- 101000582936 Homo sapiens Pleckstrin Proteins 0.000 description 2
- 101001087352 Homo sapiens Poly(U)-binding-splicing factor PUF60 Proteins 0.000 description 2
- 101001094649 Homo sapiens Popeye domain-containing protein 3 Proteins 0.000 description 2
- 101000976215 Homo sapiens Probable ribonuclease ZC3H12D Proteins 0.000 description 2
- 101001117517 Homo sapiens Prostaglandin E2 receptor EP3 subtype Proteins 0.000 description 2
- 101001117509 Homo sapiens Prostaglandin E2 receptor EP4 subtype Proteins 0.000 description 2
- 101000981455 Homo sapiens Prostate androgen-regulated mucin-like protein 1 Proteins 0.000 description 2
- 101000933604 Homo sapiens Protein BTG2 Proteins 0.000 description 2
- 101001057166 Homo sapiens Protein EVI2A Proteins 0.000 description 2
- 101001021281 Homo sapiens Protein HEXIM1 Proteins 0.000 description 2
- 101000713957 Homo sapiens Protein RUFY3 Proteins 0.000 description 2
- 101000893493 Homo sapiens Protein flightless-1 homolog Proteins 0.000 description 2
- 101000995264 Homo sapiens Protein kinase C-binding protein NELL2 Proteins 0.000 description 2
- 101001122742 Homo sapiens Protein phosphatase 1 regulatory inhibitor subunit 16B Proteins 0.000 description 2
- 101000601993 Homo sapiens Protocadherin gamma-C3 Proteins 0.000 description 2
- 101000755798 Homo sapiens Putative uncharacterized protein encoded by RHPN1-AS1 Proteins 0.000 description 2
- 101001089243 Homo sapiens RILP-like protein 2 Proteins 0.000 description 2
- 101001106821 Homo sapiens Rab11 family-interacting protein 1 Proteins 0.000 description 2
- 101000712969 Homo sapiens Ras association domain-containing protein 5 Proteins 0.000 description 2
- 101001092176 Homo sapiens Ras-GEF domain-containing family member 1B Proteins 0.000 description 2
- 101001110313 Homo sapiens Ras-related C3 botulinum toxin substrate 2 Proteins 0.000 description 2
- 101000580351 Homo sapiens Respirasome Complex Assembly Factor 1 Proteins 0.000 description 2
- 101001100103 Homo sapiens Retinoic acid-induced protein 2 Proteins 0.000 description 2
- 101000856696 Homo sapiens Rho GDP-dissociation inhibitor 2 Proteins 0.000 description 2
- 101001092004 Homo sapiens Rho GTPase-activating protein 21 Proteins 0.000 description 2
- 101001091991 Homo sapiens Rho GTPase-activating protein 25 Proteins 0.000 description 2
- 101001075565 Homo sapiens Rho GTPase-activating protein 30 Proteins 0.000 description 2
- 101000666661 Homo sapiens Rho-related GTP-binding protein RhoU Proteins 0.000 description 2
- 101001111742 Homo sapiens Rhombotin-2 Proteins 0.000 description 2
- 101000692943 Homo sapiens Ribonuclease K6 Proteins 0.000 description 2
- 101000693722 Homo sapiens SAM and SH3 domain-containing protein 3 Proteins 0.000 description 2
- 101000637795 Homo sapiens SH3 domain and tetratricopeptide repeat-containing protein 2 Proteins 0.000 description 2
- 101000633786 Homo sapiens SLAM family member 6 Proteins 0.000 description 2
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 description 2
- 101000708790 Homo sapiens SPARC-related modular calcium-binding protein 2 Proteins 0.000 description 2
- 101000729945 Homo sapiens Serine/threonine-protein kinase PLK2 Proteins 0.000 description 2
- 101000595531 Homo sapiens Serine/threonine-protein kinase pim-1 Proteins 0.000 description 2
- 101000868472 Homo sapiens Sialoadhesin Proteins 0.000 description 2
- 101000654495 Homo sapiens Signal-induced proliferation-associated 1-like protein 1 Proteins 0.000 description 2
- 101000835928 Homo sapiens Signal-regulatory protein gamma Proteins 0.000 description 2
- 101000688930 Homo sapiens Signaling threshold-regulating transmembrane adapter 1 Proteins 0.000 description 2
- 101000587445 Homo sapiens Single-stranded DNA-binding protein 4 Proteins 0.000 description 2
- 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 description 2
- 101000687654 Homo sapiens Sorting nexin-20 Proteins 0.000 description 2
- 101000693265 Homo sapiens Sphingosine 1-phosphate receptor 1 Proteins 0.000 description 2
- 101000587717 Homo sapiens Sulfide:quinone oxidoreductase, mitochondrial Proteins 0.000 description 2
- 101000659053 Homo sapiens Synaptopodin-2 Proteins 0.000 description 2
- 101000772109 Homo sapiens T cell receptor alpha variable 20 Proteins 0.000 description 2
- 101000606209 Homo sapiens T cell receptor beta variable 5-4 Proteins 0.000 description 2
- 101000716124 Homo sapiens T-cell surface glycoprotein CD1c Proteins 0.000 description 2
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
- 101000762938 Homo sapiens TOX high mobility group box family member 4 Proteins 0.000 description 2
- 101000651298 Homo sapiens TRAF-interacting protein with FHA domain-containing protein A Proteins 0.000 description 2
- 101000890836 Homo sapiens TRAF3-interacting JNK-activating modulator Proteins 0.000 description 2
- 101000837987 Homo sapiens Tandem C2 domains nuclear protein Proteins 0.000 description 2
- 101000796022 Homo sapiens Thioredoxin-interacting protein Proteins 0.000 description 2
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 description 2
- 101000837837 Homo sapiens Transcription factor EC Proteins 0.000 description 2
- 101000787972 Homo sapiens Transmembrane protein 132C Proteins 0.000 description 2
- 101000638010 Homo sapiens Transmembrane protein 273 Proteins 0.000 description 2
- 101000801298 Homo sapiens Transmembrane protein 44 Proteins 0.000 description 2
- 101000855253 Homo sapiens Transmembrane protein C16orf54 Proteins 0.000 description 2
- 101000766345 Homo sapiens Tribbles homolog 3 Proteins 0.000 description 2
- 101000835646 Homo sapiens Tubulin beta-2B chain Proteins 0.000 description 2
- 101000830568 Homo sapiens Tumor necrosis factor alpha-induced protein 2 Proteins 0.000 description 2
- 101000830570 Homo sapiens Tumor necrosis factor alpha-induced protein 3 Proteins 0.000 description 2
- 101000801232 Homo sapiens Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 2
- 101000617285 Homo sapiens Tyrosine-protein phosphatase non-receptor type 6 Proteins 0.000 description 2
- 101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 description 2
- 101000760212 Homo sapiens Zinc finger protein 33B Proteins 0.000 description 2
- 101000723920 Homo sapiens Zinc finger protein 40 Proteins 0.000 description 2
- 101000614806 Homo sapiens cAMP-dependent protein kinase type II-beta regulatory subunit Proteins 0.000 description 2
- 101000795753 Homo sapiens mRNA decay activator protein ZFP36 Proteins 0.000 description 2
- 108010013958 Ikaros Transcription Factor Proteins 0.000 description 2
- 102000017182 Ikaros Transcription Factor Human genes 0.000 description 2
- 101710139965 Immunoglobulin kappa constant Proteins 0.000 description 2
- 102100029610 Immunoglobulin lambda constant 1 Human genes 0.000 description 2
- 102100025876 Immunoglobulin lambda variable 3-25 Human genes 0.000 description 2
- 102100036399 Importin-11 Human genes 0.000 description 2
- 102100025509 Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Human genes 0.000 description 2
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 2
- 102100022338 Integrin alpha-M Human genes 0.000 description 2
- 102100038069 Interferon regulatory factor 8 Human genes 0.000 description 2
- 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 2
- 102100026017 Interleukin-1 receptor type 2 Human genes 0.000 description 2
- 102100030236 Interleukin-10 receptor subunit alpha Human genes 0.000 description 2
- 102000013462 Interleukin-12 Human genes 0.000 description 2
- 108010065805 Interleukin-12 Proteins 0.000 description 2
- 102000000588 Interleukin-2 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 108010038453 Interleukin-2 Receptors Proteins 0.000 description 2
- 102000010789 Interleukin-2 Receptors Human genes 0.000 description 2
- 102100021592 Interleukin-7 Human genes 0.000 description 2
- 108010002586 Interleukin-7 Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102100031386 Isochorismatase domain-containing protein 1 Human genes 0.000 description 2
- 102100023430 Junctional adhesion molecule B Human genes 0.000 description 2
- 102100023437 Junctional adhesion molecule-like Human genes 0.000 description 2
- 102100023678 Killer cell lectin-like receptor subfamily B member 1 Human genes 0.000 description 2
- 102100037690 Kinesin-like protein KIF21B Human genes 0.000 description 2
- 101710197072 Lectin 1 Proteins 0.000 description 2
- WQWSMEOYXJTFRU-GUBZILKMSA-N Leu-Glu-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O WQWSMEOYXJTFRU-GUBZILKMSA-N 0.000 description 2
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 2
- ONPJGOIVICHWBW-BZSNNMDCSA-N Leu-Lys-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ONPJGOIVICHWBW-BZSNNMDCSA-N 0.000 description 2
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 2
- 108010017736 Leukocyte Immunoglobulin-like Receptor B1 Proteins 0.000 description 2
- 102100025584 Leukocyte immunoglobulin-like receptor subfamily B member 1 Human genes 0.000 description 2
- 102100027120 Low-density lipoprotein receptor-related protein 12 Human genes 0.000 description 2
- 102100027105 Lymphocyte-specific protein 1 Human genes 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 102100038213 Lysosome-associated membrane glycoprotein 3 Human genes 0.000 description 2
- 102100025354 Macrophage mannose receptor 1 Human genes 0.000 description 2
- 102100021285 Macrophage-expressed gene 1 protein Human genes 0.000 description 2
- 102100038245 Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA Human genes 0.000 description 2
- 102100030612 Mast cell carboxypeptidase A Human genes 0.000 description 2
- 102100032512 Membrane-spanning 4-domains subfamily A member 7 Human genes 0.000 description 2
- 102100036103 Microfibril-associated glycoprotein 4 Human genes 0.000 description 2
- 108010009513 Mitochondrial Aldehyde Dehydrogenase Proteins 0.000 description 2
- 102100028194 Mitogen-activated protein kinase kinase kinase kinase 4 Human genes 0.000 description 2
- 102100032877 Multidrug and toxin extrusion protein 1 Human genes 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 101000890749 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) F420-dependent hydroxymycolic acid dehydrogenase Proteins 0.000 description 2
- 102100036639 Myosin-11 Human genes 0.000 description 2
- 102100039337 NF-kappa-B inhibitor alpha Human genes 0.000 description 2
- 102100034394 NFAT activation molecule 1 Human genes 0.000 description 2
- 102100023382 NLR family CARD domain-containing protein 3 Human genes 0.000 description 2
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 2
- 102100036942 Nck-associated protein 1-like Human genes 0.000 description 2
- 102100038878 Neuropeptide Y receptor type 1 Human genes 0.000 description 2
- 102100023617 Neutrophil cytosol factor 4 Human genes 0.000 description 2
- 108700002045 Nod2 Signaling Adaptor Proteins 0.000 description 2
- 101150083031 Nod2 gene Proteins 0.000 description 2
- 102100022646 Normal mucosa of esophagus-specific gene 1 protein Human genes 0.000 description 2
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 2
- 102100022395 Nucleosome assembly protein 1-like 2 Human genes 0.000 description 2
- 102100029441 Nucleotide-binding oligomerization domain-containing protein 2 Human genes 0.000 description 2
- 102100032751 Olfactomedin-like protein 1 Human genes 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 102100035700 Outer dynein arm-docking complex subunit 4 Human genes 0.000 description 2
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102100024894 PR domain zinc finger protein 1 Human genes 0.000 description 2
- 102000036673 PRAME Human genes 0.000 description 2
- 108060006580 PRAME Proteins 0.000 description 2
- 102100039157 PTB-containing, cubilin and LRP1-interacting protein Human genes 0.000 description 2
- 102100020749 Pantetheinase Human genes 0.000 description 2
- 102100040350 Peptidyl-prolyl cis-trans isomerase FKBP14 Human genes 0.000 description 2
- 102100035787 Period circadian protein homolog 2 Human genes 0.000 description 2
- 102100036635 Phosphoglucomutase-like protein 5 Human genes 0.000 description 2
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 2
- 102100028238 Phosphoinositide 3-kinase adapter protein 1 Human genes 0.000 description 2
- 102100039472 Phosphoinositide-3-kinase-interacting protein 1 Human genes 0.000 description 2
- 108010069381 Platelet Endothelial Cell Adhesion Molecule-1 Proteins 0.000 description 2
- 102100026554 Platelet-derived growth factor receptor-like protein Human genes 0.000 description 2
- 102100030264 Pleckstrin Human genes 0.000 description 2
- 102100033008 Poly(U)-binding-splicing factor PUF60 Human genes 0.000 description 2
- 102100035477 Popeye domain-containing protein 3 Human genes 0.000 description 2
- 108010009975 Positive Regulatory Domain I-Binding Factor 1 Proteins 0.000 description 2
- XYHMFGGWNOFUOU-QXEWZRGKSA-N Pro-Ile-Gly Chemical compound OC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 XYHMFGGWNOFUOU-QXEWZRGKSA-N 0.000 description 2
- 102100031145 Probable low affinity copper uptake protein 2 Human genes 0.000 description 2
- 102100023884 Probable ribonuclease ZC3H12D Human genes 0.000 description 2
- 102100036365 Proprotein convertase subtilisin/kexin type 5 Human genes 0.000 description 2
- 102100024447 Prostaglandin E2 receptor EP3 subtype Human genes 0.000 description 2
- 102100024450 Prostaglandin E2 receptor EP4 subtype Human genes 0.000 description 2
- 102100024055 Prostate androgen-regulated mucin-like protein 1 Human genes 0.000 description 2
- 102100026034 Protein BTG2 Human genes 0.000 description 2
- 102100027246 Protein EVI2A Human genes 0.000 description 2
- 102100036452 Protein RUFY3 Human genes 0.000 description 2
- 102000015855 Protein kinase C, theta Human genes 0.000 description 2
- 102100034433 Protein kinase C-binding protein NELL2 Human genes 0.000 description 2
- 102100028740 Protein phosphatase 1 regulatory inhibitor subunit 16B Human genes 0.000 description 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
- 102100037560 Protocadherin gamma-C3 Human genes 0.000 description 2
- 102100022418 Putative uncharacterized protein encoded by RHPN1-AS1 Human genes 0.000 description 2
- 102100033758 RILP-like protein 2 Human genes 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 102100021315 Rab11 family-interacting protein 1 Human genes 0.000 description 2
- 102100033239 Ras association domain-containing protein 5 Human genes 0.000 description 2
- 102100035583 Ras-GEF domain-containing family member 1B Human genes 0.000 description 2
- 102100022129 Ras-related C3 botulinum toxin substrate 2 Human genes 0.000 description 2
- 102100037415 Regulator of G-protein signaling 3 Human genes 0.000 description 2
- 101710140411 Regulator of G-protein signaling 3 Proteins 0.000 description 2
- 102100027558 Respirasome Complex Assembly Factor 1 Human genes 0.000 description 2
- 102100038452 Retinoic acid-induced protein 2 Human genes 0.000 description 2
- 102100025622 Rho GDP-dissociation inhibitor 2 Human genes 0.000 description 2
- 102100027660 Rho GTPase-activating protein 15 Human genes 0.000 description 2
- 102100035753 Rho GTPase-activating protein 21 Human genes 0.000 description 2
- 102100035759 Rho GTPase-activating protein 25 Human genes 0.000 description 2
- 102100020887 Rho GTPase-activating protein 30 Human genes 0.000 description 2
- 102100038399 Rho-related GTP-binding protein RhoU Human genes 0.000 description 2
- 102100023876 Rhombotin-2 Human genes 0.000 description 2
- 102100026386 Ribonuclease K6 Human genes 0.000 description 2
- 102100025544 SAM and SH3 domain-containing protein 3 Human genes 0.000 description 2
- 102100032022 SH3 domain and tetratricopeptide repeat-containing protein 2 Human genes 0.000 description 2
- 102000000395 SH3 domains Human genes 0.000 description 2
- 108050008861 SH3 domains Proteins 0.000 description 2
- 102100029197 SLAM family member 6 Human genes 0.000 description 2
- 101710083287 SLAM family member 7 Proteins 0.000 description 2
- 108091006734 SLC22A3 Proteins 0.000 description 2
- 108091006660 SLC9A9 Proteins 0.000 description 2
- 102100032724 SPARC-related modular calcium-binding protein 2 Human genes 0.000 description 2
- 102100031462 Serine/threonine-protein kinase PLK2 Human genes 0.000 description 2
- 102100036077 Serine/threonine-protein kinase pim-1 Human genes 0.000 description 2
- 102100032855 Sialoadhesin Human genes 0.000 description 2
- 102100031444 Signal-induced proliferation-associated 1-like protein 1 Human genes 0.000 description 2
- 102100025795 Signal-regulatory protein gamma Human genes 0.000 description 2
- 102100024453 Signaling threshold-regulating transmembrane adapter 1 Human genes 0.000 description 2
- 102100029702 Single-stranded DNA-binding protein 4 Human genes 0.000 description 2
- 102100027339 Slit homolog 3 protein Human genes 0.000 description 2
- 206010041067 Small cell lung cancer Diseases 0.000 description 2
- 102100029967 Sodium/hydrogen exchanger 9 Human genes 0.000 description 2
- 102100020884 Sodium/myo-inositol cotransporter Human genes 0.000 description 2
- 102100024801 Sorting nexin-20 Human genes 0.000 description 2
- 102100025750 Sphingosine 1-phosphate receptor 1 Human genes 0.000 description 2
- 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 description 2
- 102100024519 Src-like-adapter Human genes 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 108090000787 Subtilisin Proteins 0.000 description 2
- 102100031138 Sulfide:quinone oxidoreductase, mitochondrial Human genes 0.000 description 2
- 102100035603 Synaptopodin-2 Human genes 0.000 description 2
- 230000006044 T cell activation Effects 0.000 description 2
- 101710166606 T cell receptor alpha variable 20 Proteins 0.000 description 2
- 101710200263 T cell receptor delta variable 2 Proteins 0.000 description 2
- 102100036014 T-cell surface glycoprotein CD1c Human genes 0.000 description 2
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
- 102000003715 TNF receptor-associated factor 4 Human genes 0.000 description 2
- 108090000008 TNF receptor-associated factor 4 Proteins 0.000 description 2
- 102100026749 TOX high mobility group box family member 4 Human genes 0.000 description 2
- 102100027651 TRAF-interacting protein with FHA domain-containing protein A Human genes 0.000 description 2
- 102100040128 TRAF3-interacting JNK-activating modulator Human genes 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 102100028544 Tandem C2 domains nuclear protein Human genes 0.000 description 2
- 102100031344 Thioredoxin-interacting protein Human genes 0.000 description 2
- 101150106297 Top1mt gene Proteins 0.000 description 2
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 description 2
- 102100028503 Transcription factor EC Human genes 0.000 description 2
- 102100025916 Transmembrane protein 132C Human genes 0.000 description 2
- 102100032076 Transmembrane protein 273 Human genes 0.000 description 2
- 102100033738 Transmembrane protein 44 Human genes 0.000 description 2
- 102100026588 Transmembrane protein C16orf54 Human genes 0.000 description 2
- 102100026390 Tribbles homolog 3 Human genes 0.000 description 2
- 102100026248 Tubulin beta-2B chain Human genes 0.000 description 2
- 108010047933 Tumor Necrosis Factor alpha-Induced Protein 3 Proteins 0.000 description 2
- 102100024595 Tumor necrosis factor alpha-induced protein 2 Human genes 0.000 description 2
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 2
- 102100033254 Tumor suppressor ARF Human genes 0.000 description 2
- 101710102803 Tumor suppressor ARF Proteins 0.000 description 2
- HSVPZJLMPLMPOX-BPNCWPANSA-N Tyr-Arg-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O HSVPZJLMPLMPOX-BPNCWPANSA-N 0.000 description 2
- 108010005656 Ubiquitin Thiolesterase Proteins 0.000 description 2
- 102100024250 Ubiquitin carboxyl-terminal hydrolase CYLD Human genes 0.000 description 2
- 102100025038 Ubiquitin carboxyl-terminal hydrolase isozyme L1 Human genes 0.000 description 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 2
- ZTKGDWOUYRRAOQ-ULQDDVLXSA-N Val-His-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N ZTKGDWOUYRRAOQ-ULQDDVLXSA-N 0.000 description 2
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 2
- 102100024657 Zinc finger protein 33B Human genes 0.000 description 2
- 102100028440 Zinc finger protein 40 Human genes 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 102000005922 amidase Human genes 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000006023 anti-tumor response Effects 0.000 description 2
- 108010013835 arginine glutamate Proteins 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 230000003416 augmentation Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 108010079292 betaglycan Proteins 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 206010005084 bladder transitional cell carcinoma Diseases 0.000 description 2
- 201000001528 bladder urothelial carcinoma Diseases 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000004970 cd4 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 108010015426 connexin 45 Proteins 0.000 description 2
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 2
- 230000001461 cytolytic effect Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 108010038795 estrogen receptors Proteins 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- 108010020688 glycylhistidine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 201000010536 head and neck cancer Diseases 0.000 description 2
- 208000014829 head and neck neoplasm Diseases 0.000 description 2
- 201000000459 head and neck squamous cell carcinoma Diseases 0.000 description 2
- 108010028295 histidylhistidine Proteins 0.000 description 2
- 108010092114 histidylphenylalanine Proteins 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000011221 initial treatment Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 230000021633 leukocyte mediated immunity Effects 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 238000011866 long-term treatment Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 230000002132 lysosomal effect Effects 0.000 description 2
- 102100031622 mRNA decay activator protein ZFP36 Human genes 0.000 description 2
- 108010086154 neutrophil cytosol factor 40K Proteins 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 238000009021 pre-vaccination Methods 0.000 description 2
- 208000037821 progressive disease Diseases 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- 208000000587 small cell lung carcinoma Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 206010041823 squamous cell carcinoma Diseases 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 2
- 108010020532 tyrosyl-proline Proteins 0.000 description 2
- 239000012646 vaccine adjuvant Substances 0.000 description 2
- 229940124931 vaccine adjuvant Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- YDRYQBCOLJPFFX-REOHCLBHSA-N (2r)-2-amino-3-(1,1,2,2-tetrafluoroethylsulfanyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CSC(F)(F)C(F)F YDRYQBCOLJPFFX-REOHCLBHSA-N 0.000 description 1
- PKOHVHWNGUHYRE-ZFWWWQNUSA-N (2s)-1-[2-[[(2s)-2-amino-3-(1h-indol-3-yl)propanoyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound O=C([C@H](CC=1C2=CC=CC=C2NC=1)N)NCC(=O)N1CCC[C@H]1C(O)=O PKOHVHWNGUHYRE-ZFWWWQNUSA-N 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 101150106899 28 gene Proteins 0.000 description 1
- 108020005096 28S Ribosomal RNA Proteins 0.000 description 1
- 101150051922 29 gene Proteins 0.000 description 1
- 101150110188 30 gene Proteins 0.000 description 1
- 101150070234 31 gene Proteins 0.000 description 1
- ROMPPAWVATWIKR-UHFFFAOYSA-N 4-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]butanoic acid Chemical compound O1C(CCCC(=O)O)=NC(C=2C=CC(Cl)=CC=2)=N1 ROMPPAWVATWIKR-UHFFFAOYSA-N 0.000 description 1
- 102000017919 ADRB2 Human genes 0.000 description 1
- 101150075418 ARHGAP15 gene Proteins 0.000 description 1
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- SVBXIUDNTRTKHE-CIUDSAMLSA-N Ala-Arg-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O SVBXIUDNTRTKHE-CIUDSAMLSA-N 0.000 description 1
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 1
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 1
- PUBLUECXJRHTBK-ACZMJKKPSA-N Ala-Glu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O PUBLUECXJRHTBK-ACZMJKKPSA-N 0.000 description 1
- LJFNNUBZSZCZFN-WHFBIAKZSA-N Ala-Gly-Cys Chemical compound N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O LJFNNUBZSZCZFN-WHFBIAKZSA-N 0.000 description 1
- ZPXCNXMJEZKRLU-LSJOCFKGSA-N Ala-His-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CN=CN1 ZPXCNXMJEZKRLU-LSJOCFKGSA-N 0.000 description 1
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 1
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
- GFEDXKNBZMPEDM-KZVJFYERSA-N Ala-Met-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFEDXKNBZMPEDM-KZVJFYERSA-N 0.000 description 1
- XRUJOVRWNMBAAA-NHCYSSNCSA-N Ala-Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 XRUJOVRWNMBAAA-NHCYSSNCSA-N 0.000 description 1
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 1
- IORKCNUBHNIMKY-CIUDSAMLSA-N Ala-Pro-Glu Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O IORKCNUBHNIMKY-CIUDSAMLSA-N 0.000 description 1
- 102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 102000035485 Allograft inflammatory factor 1 Human genes 0.000 description 1
- 108091010877 Allograft inflammatory factor 1 Proteins 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000710929 Alphavirus Species 0.000 description 1
- 108010052469 Apolipoprotein L1 Proteins 0.000 description 1
- 102000018757 Apolipoprotein L1 Human genes 0.000 description 1
- 241000272478 Aquila Species 0.000 description 1
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 1
- HPSVTWMFWCHKFN-GARJFASQSA-N Arg-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O HPSVTWMFWCHKFN-GARJFASQSA-N 0.000 description 1
- PAPSMOYMQDWIOR-AVGNSLFASA-N Arg-Lys-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PAPSMOYMQDWIOR-AVGNSLFASA-N 0.000 description 1
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DATSKXOXPUAOLK-KKUMJFAQSA-N Asn-Tyr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O DATSKXOXPUAOLK-KKUMJFAQSA-N 0.000 description 1
- YNCHFVRXEQFPBY-BQBZGAKWSA-N Asp-Gly-Arg Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N YNCHFVRXEQFPBY-BQBZGAKWSA-N 0.000 description 1
- DWOGMPWRQQWPPF-GUBZILKMSA-N Asp-Leu-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O DWOGMPWRQQWPPF-GUBZILKMSA-N 0.000 description 1
- MVRGBQGZSDJBSM-GMOBBJLQSA-N Asp-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)N MVRGBQGZSDJBSM-GMOBBJLQSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 101000840545 Bacillus thuringiensis L-isoleucine-4-hydroxylase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 description 1
- 102000015735 Beta-catenin Human genes 0.000 description 1
- 108060000903 Beta-catenin Proteins 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- BHKSYEZGBQDNRW-SCGRZTRASA-N C(CCC(=O)O)(=O)O.N[C@@H](CCCNC(N)=N)C(=O)O.N[C@@H](CCCNC(N)=N)C(=O)O Chemical compound C(CCC(=O)O)(=O)O.N[C@@H](CCCNC(N)=N)C(=O)O.N[C@@H](CCCNC(N)=N)C(=O)O BHKSYEZGBQDNRW-SCGRZTRASA-N 0.000 description 1
- 101710149815 C-C chemokine receptor type 2 Proteins 0.000 description 1
- 102100036842 C-C motif chemokine 19 Human genes 0.000 description 1
- 102100034871 C-C motif chemokine 8 Human genes 0.000 description 1
- 102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 1
- 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 1
- 102100028699 C-type lectin domain family 4 member E Human genes 0.000 description 1
- 102000002110 C2 domains Human genes 0.000 description 1
- 108050009459 C2 domains Proteins 0.000 description 1
- 102100025222 CD63 antigen Human genes 0.000 description 1
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
- 101100243943 Caenorhabditis elegans pid-5 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
- 102100039510 Cancer/testis antigen 2 Human genes 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 108090000426 Caspase-1 Proteins 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010082161 Chemokine CCL19 Proteins 0.000 description 1
- 102000003805 Chemokine CCL19 Human genes 0.000 description 1
- 108010083701 Chemokine CCL22 Proteins 0.000 description 1
- 102000006433 Chemokine CCL22 Human genes 0.000 description 1
- 108010055204 Chemokine CCL8 Proteins 0.000 description 1
- 102000000012 Chemokine CCL8 Human genes 0.000 description 1
- 108010008951 Chemokine CXCL12 Proteins 0.000 description 1
- 102000006573 Chemokine CXCL12 Human genes 0.000 description 1
- 108010014414 Chemokine CXCL2 Proteins 0.000 description 1
- 102000016951 Chemokine CXCL2 Human genes 0.000 description 1
- 108010014231 Chemokine CXCL9 Proteins 0.000 description 1
- 102000016937 Chemokine CXCL9 Human genes 0.000 description 1
- 102000009410 Chemokine receptor Human genes 0.000 description 1
- 108050000299 Chemokine receptor Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 241001646579 Coryphaenoides cinereus Species 0.000 description 1
- 102100025278 Coxsackievirus and adenovirus receptor Human genes 0.000 description 1
- IZUNQDRIAOLWCN-YUMQZZPRSA-N Cys-Leu-Gly Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N IZUNQDRIAOLWCN-YUMQZZPRSA-N 0.000 description 1
- 102100025620 Cytochrome b-245 light chain Human genes 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102100024607 DNA topoisomerase 1 Human genes 0.000 description 1
- 101710119265 DNA topoisomerase 1 Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 101100412663 Danio rerio rasgef1bb gene Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 102100038591 Endothelial cell-selective adhesion molecule Human genes 0.000 description 1
- 102100039621 Epithelial-stromal interaction protein 1 Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 108091007024 FBXOs Proteins 0.000 description 1
- 102000036355 FBXOs Human genes 0.000 description 1
- 101150066968 GPR183 gene Proteins 0.000 description 1
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
- 108091006109 GTPases Proteins 0.000 description 1
- 102100035212 Gamma-aminobutyric acid type B receptor subunit 1 Human genes 0.000 description 1
- JESJDAAGXULQOP-CIUDSAMLSA-N Gln-Arg-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)CN=C(N)N JESJDAAGXULQOP-CIUDSAMLSA-N 0.000 description 1
- XEYMBRRKIFYQMF-GUBZILKMSA-N Gln-Asp-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O XEYMBRRKIFYQMF-GUBZILKMSA-N 0.000 description 1
- LPYPANUXJGFMGV-FXQIFTODSA-N Gln-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N LPYPANUXJGFMGV-FXQIFTODSA-N 0.000 description 1
- VSXBYIJUAXPAAL-WDSKDSINSA-N Gln-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O VSXBYIJUAXPAAL-WDSKDSINSA-N 0.000 description 1
- JNEITCMDYWKPIW-GUBZILKMSA-N Gln-His-Cys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)N)N JNEITCMDYWKPIW-GUBZILKMSA-N 0.000 description 1
- LKVCNGLNTAPMSZ-JYJNAYRXSA-N Gln-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)N)N LKVCNGLNTAPMSZ-JYJNAYRXSA-N 0.000 description 1
- FYAULIGIFPPOAA-ZPFDUUQYSA-N Gln-Ile-Met Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O FYAULIGIFPPOAA-ZPFDUUQYSA-N 0.000 description 1
- GHAXJVNBAKGWEJ-AVGNSLFASA-N Gln-Ser-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GHAXJVNBAKGWEJ-AVGNSLFASA-N 0.000 description 1
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 1
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 1
- ZJICFHQSPWFBKP-AVGNSLFASA-N Glu-Asn-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZJICFHQSPWFBKP-AVGNSLFASA-N 0.000 description 1
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 1
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 1
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 1
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 1
- WDTAKCUOIKHCTB-NKIYYHGXSA-N Glu-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N)O WDTAKCUOIKHCTB-NKIYYHGXSA-N 0.000 description 1
- DWBBKNPKDHXIAC-SRVKXCTJSA-N Glu-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(O)=O DWBBKNPKDHXIAC-SRVKXCTJSA-N 0.000 description 1
- YKBUCXNNBYZYAY-MNXVOIDGSA-N Glu-Lys-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YKBUCXNNBYZYAY-MNXVOIDGSA-N 0.000 description 1
- CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
- FQFWFZWOHOEVMZ-IHRRRGAJSA-N Glu-Phe-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O FQFWFZWOHOEVMZ-IHRRRGAJSA-N 0.000 description 1
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 1
- MIWJDJAMMKHUAR-ZVZYQTTQSA-N Glu-Trp-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)N MIWJDJAMMKHUAR-ZVZYQTTQSA-N 0.000 description 1
- FVGOGEGGQLNZGH-DZKIICNBSA-N Glu-Val-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FVGOGEGGQLNZGH-DZKIICNBSA-N 0.000 description 1
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 1
- GZUKEVBTYNNUQF-WDSKDSINSA-N Gly-Ala-Gln Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GZUKEVBTYNNUQF-WDSKDSINSA-N 0.000 description 1
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 1
- SUDUYJOBLHQAMI-WHFBIAKZSA-N Gly-Asp-Cys Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(O)=O SUDUYJOBLHQAMI-WHFBIAKZSA-N 0.000 description 1
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 1
- PDAWDNVHMUKWJR-ZETCQYMHSA-N Gly-Gly-His Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 PDAWDNVHMUKWJR-ZETCQYMHSA-N 0.000 description 1
- FSPVILZGHUJOHS-QWRGUYRKSA-N Gly-His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CNC=N1 FSPVILZGHUJOHS-QWRGUYRKSA-N 0.000 description 1
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 1
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 1
- ZZJVYSAQQMDIRD-UWVGGRQHSA-N Gly-Pro-His Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O ZZJVYSAQQMDIRD-UWVGGRQHSA-N 0.000 description 1
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- RIYIFUFFFBIOEU-KBPBESRZSA-N Gly-Tyr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 RIYIFUFFFBIOEU-KBPBESRZSA-N 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 description 1
- 108010081606 HLA-DQA2 antigen Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 201000005406 Hermansky-Pudlak syndrome 3 Diseases 0.000 description 1
- MWAJSVTZZOUOBU-IHRRRGAJSA-N His-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC1=CN=CN1 MWAJSVTZZOUOBU-IHRRRGAJSA-N 0.000 description 1
- SVVULKPWDBIPCO-BZSNNMDCSA-N His-Phe-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O SVVULKPWDBIPCO-BZSNNMDCSA-N 0.000 description 1
- 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
- 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
- 101000775489 Homo sapiens Adenylate cyclase type 6 Proteins 0.000 description 1
- 101000652570 Homo sapiens Antigen peptide transporter 1 Proteins 0.000 description 1
- 101000777599 Homo sapiens C-C chemokine receptor type 2 Proteins 0.000 description 1
- 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 description 1
- 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 description 1
- 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 1
- 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 1
- 101000766921 Homo sapiens C-type lectin domain family 4 member E Proteins 0.000 description 1
- 101000945426 Homo sapiens CB1 cannabinoid receptor-interacting protein 1 Proteins 0.000 description 1
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
- 101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 description 1
- 101000858031 Homo sapiens Coxsackievirus and adenovirus receptor Proteins 0.000 description 1
- 101000856723 Homo sapiens Cytochrome b-245 light chain Proteins 0.000 description 1
- 101000882622 Homo sapiens Endothelial cell-selective adhesion molecule Proteins 0.000 description 1
- 101000814134 Homo sapiens Epithelial-stromal interaction protein 1 Proteins 0.000 description 1
- 101001022087 Homo sapiens Gamma-aminobutyric acid type B receptor subunit 1 Proteins 0.000 description 1
- 101001037256 Homo sapiens Indoleamine 2,3-dioxygenase 1 Proteins 0.000 description 1
- 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 description 1
- 101000960954 Homo sapiens Interleukin-18 Proteins 0.000 description 1
- 101001019615 Homo sapiens Interleukin-18 receptor accessory protein Proteins 0.000 description 1
- 101000938676 Homo sapiens Liver carboxylesterase 1 Proteins 0.000 description 1
- 101001064870 Homo sapiens Lon protease homolog, mitochondrial Proteins 0.000 description 1
- 101000984710 Homo sapiens Lymphocyte-specific protein 1 Proteins 0.000 description 1
- 101001043351 Homo sapiens Lysyl oxidase homolog 4 Proteins 0.000 description 1
- 101001017597 Homo sapiens Mediator of RNA polymerase II transcription subunit 12-like protein Proteins 0.000 description 1
- 101001005728 Homo sapiens Melanoma-associated antigen 1 Proteins 0.000 description 1
- 101001057131 Homo sapiens Melanoma-associated antigen D4 Proteins 0.000 description 1
- 101001014059 Homo sapiens Metallothionein-2 Proteins 0.000 description 1
- 101100354855 Homo sapiens PYDC1 gene Proteins 0.000 description 1
- 101001123262 Homo sapiens Proline-serine-threonine phosphatase-interacting protein 2 Proteins 0.000 description 1
- 101001057168 Homo sapiens Protein EVI2B Proteins 0.000 description 1
- 101000937720 Homo sapiens Protein FAM222B Proteins 0.000 description 1
- 101000999079 Homo sapiens Radiation-inducible immediate-early gene IEX-1 Proteins 0.000 description 1
- 101000654701 Homo sapiens Semaphorin-4F Proteins 0.000 description 1
- 101000879840 Homo sapiens Serglycin Proteins 0.000 description 1
- 101000651893 Homo sapiens Slit homolog 3 protein Proteins 0.000 description 1
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
- 101000844022 Homo sapiens T cell receptor beta variable 7-9 Proteins 0.000 description 1
- 101000679304 Homo sapiens T cell receptor gamma variable 2 Proteins 0.000 description 1
- 101000946850 Homo sapiens T-lymphocyte activation antigen CD86 Proteins 0.000 description 1
- 101000835541 Homo sapiens Target of Nesh-SH3 Proteins 0.000 description 1
- 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 1
- 101000899433 Homo sapiens Transmembrane protein C1orf162 Proteins 0.000 description 1
- 101000795085 Homo sapiens Tryptase beta-2 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- HGNUKGZQASSBKQ-PCBIJLKTSA-N Ile-Asp-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HGNUKGZQASSBKQ-PCBIJLKTSA-N 0.000 description 1
- YBJWJQQBWRARLT-KBIXCLLPSA-N Ile-Gln-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O YBJWJQQBWRARLT-KBIXCLLPSA-N 0.000 description 1
- UQXADIGYEYBJEI-DJFWLOJKSA-N Ile-His-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N UQXADIGYEYBJEI-DJFWLOJKSA-N 0.000 description 1
- BBQABUDWDUKJMB-LZXPERKUSA-N Ile-Ile-Ile Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C([O-])=O BBQABUDWDUKJMB-LZXPERKUSA-N 0.000 description 1
- QZZIBQZLWBOOJH-PEDHHIEDSA-N Ile-Ile-Val Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)O QZZIBQZLWBOOJH-PEDHHIEDSA-N 0.000 description 1
- FZWVCYCYWCLQDH-NHCYSSNCSA-N Ile-Leu-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N FZWVCYCYWCLQDH-NHCYSSNCSA-N 0.000 description 1
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 1
- WLRJHVNFGAOYPS-HJPIBITLSA-N Ile-Ser-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N WLRJHVNFGAOYPS-HJPIBITLSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101800000324 Immunoglobulin A1 protease translocator Proteins 0.000 description 1
- 108010050586 Immunoglobulin J-Chains Proteins 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 description 1
- 102100022337 Integrin alpha-V Human genes 0.000 description 1
- 108010072255 Integrin alpha3beta1 Proteins 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000003810 Interleukin-18 Human genes 0.000 description 1
- 108090000171 Interleukin-18 Proteins 0.000 description 1
- 102100039898 Interleukin-18 Human genes 0.000 description 1
- 102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 108010019437 Janus Kinase 2 Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005411 L01XE02 - Gefitinib Substances 0.000 description 1
- QPRQGENIBFLVEB-BJDJZHNGSA-N Leu-Ala-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QPRQGENIBFLVEB-BJDJZHNGSA-N 0.000 description 1
- HASRFYOMVPJRPU-SRVKXCTJSA-N Leu-Arg-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HASRFYOMVPJRPU-SRVKXCTJSA-N 0.000 description 1
- LOLUPZNNADDTAA-AVGNSLFASA-N Leu-Gln-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LOLUPZNNADDTAA-AVGNSLFASA-N 0.000 description 1
- PRZVBIAOPFGAQF-SRVKXCTJSA-N Leu-Glu-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O PRZVBIAOPFGAQF-SRVKXCTJSA-N 0.000 description 1
- LLBQJYDYOLIQAI-JYJNAYRXSA-N Leu-Glu-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LLBQJYDYOLIQAI-JYJNAYRXSA-N 0.000 description 1
- LAPSXOAUPNOINL-YUMQZZPRSA-N Leu-Gly-Asp Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O LAPSXOAUPNOINL-YUMQZZPRSA-N 0.000 description 1
- KGCLIYGPQXUNLO-IUCAKERBSA-N Leu-Gly-Glu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O KGCLIYGPQXUNLO-IUCAKERBSA-N 0.000 description 1
- AOFYPTOHESIBFZ-KKUMJFAQSA-N Leu-His-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O AOFYPTOHESIBFZ-KKUMJFAQSA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 1
- SQUFDMCWMFOEBA-KKUMJFAQSA-N Leu-Ser-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SQUFDMCWMFOEBA-KKUMJFAQSA-N 0.000 description 1
- LMDVGHQPPPLYAR-IHRRRGAJSA-N Leu-Val-His Chemical compound N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O LMDVGHQPPPLYAR-IHRRRGAJSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 102100030817 Liver carboxylesterase 1 Human genes 0.000 description 1
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 1
- AAORVPFVUIHEAB-YUMQZZPRSA-N Lys-Asp-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O AAORVPFVUIHEAB-YUMQZZPRSA-N 0.000 description 1
- CNGOEHJCLVCJHN-SRVKXCTJSA-N Lys-Pro-Glu Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O CNGOEHJCLVCJHN-SRVKXCTJSA-N 0.000 description 1
- RPWTZTBIFGENIA-VOAKCMCISA-N Lys-Thr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RPWTZTBIFGENIA-VOAKCMCISA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108010009489 Lysosomal-Associated Membrane Protein 3 Proteins 0.000 description 1
- 102100021968 Lysyl oxidase homolog 4 Human genes 0.000 description 1
- 108091054437 MHC class I family Proteins 0.000 description 1
- 101710167885 Major outer membrane protein P.IB Proteins 0.000 description 1
- 108010031099 Mannose Receptor Proteins 0.000 description 1
- 102000001696 Mannosidases Human genes 0.000 description 1
- 108010054377 Mannosidases Proteins 0.000 description 1
- 102100034160 Mediator of RNA polymerase II transcription subunit 12-like protein Human genes 0.000 description 1
- 102100025050 Melanoma-associated antigen 1 Human genes 0.000 description 1
- 108010023335 Member 2 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 102100027159 Membrane primary amine oxidase Human genes 0.000 description 1
- 101710169959 Membrane protein 2 Proteins 0.000 description 1
- LMKSBGIUPVRHEH-FXQIFTODSA-N Met-Ala-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(N)=O LMKSBGIUPVRHEH-FXQIFTODSA-N 0.000 description 1
- HKRYNJSKVLZIFP-IHRRRGAJSA-N Met-Asn-Tyr Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HKRYNJSKVLZIFP-IHRRRGAJSA-N 0.000 description 1
- DNDVVILEHVMWIS-LPEHRKFASA-N Met-Asp-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DNDVVILEHVMWIS-LPEHRKFASA-N 0.000 description 1
- OOSPRDCGTLQLBP-NHCYSSNCSA-N Met-Glu-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OOSPRDCGTLQLBP-NHCYSSNCSA-N 0.000 description 1
- LPNWWHBFXPNHJG-AVGNSLFASA-N Met-Val-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN LPNWWHBFXPNHJG-AVGNSLFASA-N 0.000 description 1
- 102100031347 Metallothionein-2 Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102100033820 Mitochondrial ribosome-associated GTPase 2 Human genes 0.000 description 1
- 241001092142 Molina Species 0.000 description 1
- 108091006676 Monovalent cation:proton antiporter-3 Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101000868474 Mus musculus Sialoadhesin Proteins 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- KTHDTJVBEPMMGL-VKHMYHEASA-N N-acetyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(C)=O KTHDTJVBEPMMGL-VKHMYHEASA-N 0.000 description 1
- KTHDTJVBEPMMGL-UHFFFAOYSA-N N-acetyl-L-alanine Natural products OC(=O)C(C)NC(C)=O KTHDTJVBEPMMGL-UHFFFAOYSA-N 0.000 description 1
- 102000002452 NPR3 Human genes 0.000 description 1
- 101150066297 NPR3 gene Proteins 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 101710200212 Olfactory receptor 1 Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102100026168 P2Y purinoceptor 13 Human genes 0.000 description 1
- 102100025808 P2Y purinoceptor 14 Human genes 0.000 description 1
- 101150109471 PID2 gene Proteins 0.000 description 1
- BKWJQWJPZMUWEG-LFSVMHDDSA-N Phe-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BKWJQWJPZMUWEG-LFSVMHDDSA-N 0.000 description 1
- BFYHIHGIHGROAT-HTUGSXCWSA-N Phe-Glu-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BFYHIHGIHGROAT-HTUGSXCWSA-N 0.000 description 1
- HGNGAMWHGGANAU-WHOFXGATSA-N Phe-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 HGNGAMWHGGANAU-WHOFXGATSA-N 0.000 description 1
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 1
- HQPWNHXERZCIHP-PMVMPFDFSA-N Phe-Leu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 HQPWNHXERZCIHP-PMVMPFDFSA-N 0.000 description 1
- WKLMCMXFMQEKCX-SLFFLAALSA-N Phe-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O WKLMCMXFMQEKCX-SLFFLAALSA-N 0.000 description 1
- AAERWTUHZKLDLC-IHRRRGAJSA-N Phe-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O AAERWTUHZKLDLC-IHRRRGAJSA-N 0.000 description 1
- KUSYCSMTTHSZOA-DZKIICNBSA-N Phe-Val-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N KUSYCSMTTHSZOA-DZKIICNBSA-N 0.000 description 1
- 102100035200 Phospholipase A and acyltransferase 4 Human genes 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102100026123 Pirin Human genes 0.000 description 1
- 101710176373 Pirin Proteins 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- YFNOUBWUIIJQHF-LPEHRKFASA-N Pro-Asp-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O YFNOUBWUIIJQHF-LPEHRKFASA-N 0.000 description 1
- DIFXZGPHVCIVSQ-CIUDSAMLSA-N Pro-Gln-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O DIFXZGPHVCIVSQ-CIUDSAMLSA-N 0.000 description 1
- LCUOTSLIVGSGAU-AVGNSLFASA-N Pro-His-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LCUOTSLIVGSGAU-AVGNSLFASA-N 0.000 description 1
- SRBFGSGDNNQABI-FHWLQOOXSA-N Pro-Leu-Trp Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C(=O)[C@@H]1CCCN1 SRBFGSGDNNQABI-FHWLQOOXSA-N 0.000 description 1
- OFGUOWQVEGTVNU-DCAQKATOSA-N Pro-Lys-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OFGUOWQVEGTVNU-DCAQKATOSA-N 0.000 description 1
- DWGFLKQSGRUQTI-IHRRRGAJSA-N Pro-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1 DWGFLKQSGRUQTI-IHRRRGAJSA-N 0.000 description 1
- CGSOWZUPLOKYOR-AVGNSLFASA-N Pro-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 CGSOWZUPLOKYOR-AVGNSLFASA-N 0.000 description 1
- GZNYIXWOIUFLGO-ZJDVBMNYSA-N Pro-Thr-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZNYIXWOIUFLGO-ZJDVBMNYSA-N 0.000 description 1
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 1
- 102100029027 Proline-serine-threonine phosphatase-interacting protein 2 Human genes 0.000 description 1
- 108010044159 Proprotein Convertases Proteins 0.000 description 1
- 102000006437 Proprotein Convertases Human genes 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 102100027249 Protein EVI2B Human genes 0.000 description 1
- 102100027295 Protein FAM222B Human genes 0.000 description 1
- 102000005569 Protein Phosphatase 1 Human genes 0.000 description 1
- 108010059000 Protein Phosphatase 1 Proteins 0.000 description 1
- 101710179016 Protein gamma Proteins 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 102100039892 Pyrin domain-containing protein 1 Human genes 0.000 description 1
- 241001454523 Quillaja saponaria Species 0.000 description 1
- 235000009001 Quillaja saponaria Nutrition 0.000 description 1
- 108010003201 RGH 0205 Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 230000021839 RNA stabilization Effects 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 102100023320 Ral guanine nucleotide dissociation stimulator Human genes 0.000 description 1
- 108050008437 Ral guanine nucleotide dissociation stimulator Proteins 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 102100021035 Regulator of G-protein signaling 18 Human genes 0.000 description 1
- 101710148110 Regulator of G-protein signaling 18 Proteins 0.000 description 1
- 108010053823 Rho Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
- 102000042463 Rho family Human genes 0.000 description 1
- 108091078243 Rho family Proteins 0.000 description 1
- 108700019718 SAM Domain and HD Domain-Containing Protein 1 Proteins 0.000 description 1
- 101150114242 SAMHD1 gene Proteins 0.000 description 1
- 108091006567 SLC31A2 Proteins 0.000 description 1
- 108091006268 SLC5A3 Proteins 0.000 description 1
- 108091006647 SLC9A1 Proteins 0.000 description 1
- 101700004678 SLIT3 Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101001037255 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Indoleamine 2,3-dioxygenase Proteins 0.000 description 1
- 241001222774 Salmonella enterica subsp. enterica serovar Minnesota Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 108050007376 Semaphorin 4F Proteins 0.000 description 1
- BCKYYTVFBXHPOG-ACZMJKKPSA-N Ser-Asn-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N BCKYYTVFBXHPOG-ACZMJKKPSA-N 0.000 description 1
- BYIROAKULFFTEK-CIUDSAMLSA-N Ser-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO BYIROAKULFFTEK-CIUDSAMLSA-N 0.000 description 1
- GHPQVUYZQQGEDA-BIIVOSGPSA-N Ser-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N)C(=O)O GHPQVUYZQQGEDA-BIIVOSGPSA-N 0.000 description 1
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 1
- WLJPJRGQRNCIQS-ZLUOBGJFSA-N Ser-Ser-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O WLJPJRGQRNCIQS-ZLUOBGJFSA-N 0.000 description 1
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 1
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- 102100037344 Serglycin Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 101710082933 Single-strand DNA-binding protein Proteins 0.000 description 1
- 102100036929 Solute carrier family 22 member 3 Human genes 0.000 description 1
- 102100037253 Solute carrier family 45 member 3 Human genes 0.000 description 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
- 102100034333 Synaptic vesicular amine transporter Human genes 0.000 description 1
- 101710164184 Synaptic vesicular amine transporter Proteins 0.000 description 1
- 101710092823 T cell receptor beta variable 5-4 Proteins 0.000 description 1
- 102100032192 T cell receptor beta variable 7-9 Human genes 0.000 description 1
- 102100022581 T cell receptor gamma variable 2 Human genes 0.000 description 1
- 108700042075 T-Cell Receptor Genes Proteins 0.000 description 1
- 102100034924 T-lymphocyte activation antigen CD86 Human genes 0.000 description 1
- 240000002033 Tacca leontopetaloides Species 0.000 description 1
- 102100026544 Target of Nesh-SH3 Human genes 0.000 description 1
- 108010033711 Telomeric Repeat Binding Protein 1 Proteins 0.000 description 1
- 102100036497 Telomeric repeat-binding factor 1 Human genes 0.000 description 1
- ZUUDNCOCILSYAM-KKHAAJSZSA-N Thr-Asp-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZUUDNCOCILSYAM-KKHAAJSZSA-N 0.000 description 1
- GUZGCDIZVGODML-NKIYYHGXSA-N Thr-Gln-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O GUZGCDIZVGODML-NKIYYHGXSA-N 0.000 description 1
- MQUZMZBFKCHVOB-HJGDQZAQSA-N Thr-Gln-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O MQUZMZBFKCHVOB-HJGDQZAQSA-N 0.000 description 1
- CQNFRKAKGDSJFR-NUMRIWBASA-N Thr-Glu-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O CQNFRKAKGDSJFR-NUMRIWBASA-N 0.000 description 1
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 1
- HUPLKEHTTQBXSC-YJRXYDGGSA-N Thr-Ser-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HUPLKEHTTQBXSC-YJRXYDGGSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
- 102100022518 Transmembrane protein C1orf162 Human genes 0.000 description 1
- 241000703392 Tribec virus Species 0.000 description 1
- ZJKZLNAECPIUTL-JBACZVJFSA-N Trp-Gln-Tyr Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=C(O)C=C1 ZJKZLNAECPIUTL-JBACZVJFSA-N 0.000 description 1
- CZWIHKFGHICAJX-BPUTZDHNSA-N Trp-Glu-Glu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 CZWIHKFGHICAJX-BPUTZDHNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100040939 Tubulin-tyrosine ligase Human genes 0.000 description 1
- 108020005542 Tubulin-tyrosine ligase Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- HKIUVWMZYFBIHG-KKUMJFAQSA-N Tyr-Arg-Gln Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O HKIUVWMZYFBIHG-KKUMJFAQSA-N 0.000 description 1
- KSCVLGXNQXKUAR-JYJNAYRXSA-N Tyr-Leu-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KSCVLGXNQXKUAR-JYJNAYRXSA-N 0.000 description 1
- UUJHRSTVQCFDPA-UFYCRDLUSA-N Tyr-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 UUJHRSTVQCFDPA-UFYCRDLUSA-N 0.000 description 1
- 102100039094 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- QHFQQRKNGCXTHL-AUTRQRHGSA-N Val-Gln-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QHFQQRKNGCXTHL-AUTRQRHGSA-N 0.000 description 1
- NXRAUQGGHPCJIB-RCOVLWMOSA-N Val-Gly-Asn Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O NXRAUQGGHPCJIB-RCOVLWMOSA-N 0.000 description 1
- APEBUJBRGCMMHP-HJWJTTGWSA-N Val-Ile-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 APEBUJBRGCMMHP-HJWJTTGWSA-N 0.000 description 1
- VPGCVZRRBYOGCD-AVGNSLFASA-N Val-Lys-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O VPGCVZRRBYOGCD-AVGNSLFASA-N 0.000 description 1
- XBJKAZATRJBDCU-GUBZILKMSA-N Val-Pro-Ala Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O XBJKAZATRJBDCU-GUBZILKMSA-N 0.000 description 1
- SJRUJQFQVLMZFW-WPRPVWTQSA-N Val-Pro-Gly Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SJRUJQFQVLMZFW-WPRPVWTQSA-N 0.000 description 1
- GVNLOVJNNDZUHS-RHYQMDGZSA-N Val-Thr-Lys Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O GVNLOVJNNDZUHS-RHYQMDGZSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 101710185494 Zinc finger protein Proteins 0.000 description 1
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- 101150116184 abi gene Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 102100021205 cAMP-dependent protein kinase type II-beta regulatory subunit Human genes 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- QUWFSKKBMDKAHK-SBOJBMMISA-A chembl2103793 Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(N=C(N)C=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(N=C(N)C=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(N=C(N)C=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(N=C(N)C=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP([O-])(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)CO)[C@@H](O)C1 QUWFSKKBMDKAHK-SBOJBMMISA-A 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 108010034075 decysin Proteins 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 230000009762 endothelial cell differentiation Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 108700020302 erbB-2 Genes Proteins 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000008805 familial cylindromatosis Diseases 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 1
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 1
- 229960002584 gefitinib Drugs 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 108010073628 glutamyl-valyl-phenylalanine Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 108010051307 glycyl-glycyl-proline Proteins 0.000 description 1
- 108010025801 glycyl-prolyl-arginine Proteins 0.000 description 1
- 102000017941 granulin Human genes 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 102000009543 guanyl-nucleotide exchange factor activity proteins Human genes 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229960002751 imiquimod Drugs 0.000 description 1
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000011493 immune profiling Methods 0.000 description 1
- 239000000568 immunological adjuvant Substances 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 208000003849 large cell carcinoma Diseases 0.000 description 1
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical class O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000009115 maintenance therapy Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- YIEDSISPYKQADU-UHFFFAOYSA-N n-acetyl-n-[2-methyl-4-[(2-methylphenyl)diazenyl]phenyl]acetamide Chemical compound C1=C(C)C(N(C(C)=O)C(=O)C)=CC=C1N=NC1=CC=CC=C1C YIEDSISPYKQADU-UHFFFAOYSA-N 0.000 description 1
- 210000004898 n-terminal fragment Anatomy 0.000 description 1
- 102000027424 natriuretic peptide receptors Human genes 0.000 description 1
- 108091008599 natriuretic peptide receptors Proteins 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 108010043412 neuropeptide Y-Y1 receptor Proteins 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- PIRWNASAJNPKHT-SHZATDIYSA-N pamp Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(C)C)C1=CC=CC=C1 PIRWNASAJNPKHT-SHZATDIYSA-N 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 108010079891 prostein Proteins 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000000790 retinal pigment Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004739 secretory vesicle Anatomy 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 108020002447 serine esterase Proteins 0.000 description 1
- 102000005428 serine esterase Human genes 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 238000011255 standard chemotherapy Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012706 support-vector machine Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000008718 systemic inflammatory response Effects 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 229940021747 therapeutic vaccine Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 108010038745 tryptophylglycine Proteins 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 150000003668 tyrosines Chemical class 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000007473 univariate analysis Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 208000037911 visceral disease Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000002759 z-score normalization Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0610949.0 | 2006-06-02 | ||
| GB0610949A GB0610949D0 (en) | 2006-06-02 | 2006-06-02 | Method |
| GB0700761A GB0700761D0 (en) | 2007-01-15 | 2007-01-15 | Method |
| GB0700761.0 | 2007-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20090017655A true KR20090017655A (ko) | 2009-02-18 |
Family
ID=38801855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020087031950A Ceased KR20090017655A (ko) | 2006-06-02 | 2007-05-31 | 환자가 면역치료제에 대한 반응자일지의 여부를 확인하는 방법 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100021424A1 (enExample) |
| EP (23) | EP2390364A1 (enExample) |
| JP (1) | JP2009538607A (enExample) |
| KR (1) | KR20090017655A (enExample) |
| AR (1) | AR061136A1 (enExample) |
| AU (1) | AU2007256383B2 (enExample) |
| BR (1) | BRPI0712497A2 (enExample) |
| CA (1) | CA2653949A1 (enExample) |
| CL (1) | CL2007001571A1 (enExample) |
| EA (1) | EA200802242A1 (enExample) |
| ES (1) | ES2539042T3 (enExample) |
| MX (1) | MX2008015372A (enExample) |
| PE (1) | PE20080742A1 (enExample) |
| TW (1) | TW200817680A (enExample) |
| WO (1) | WO2007140958A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2227558A1 (en) * | 2007-11-30 | 2010-09-15 | GlaxoSmithKline Biologicals SA | Method for classifying cancer patients as responder or non-responder to immunotherapy |
| GB0816867D0 (en) * | 2008-09-15 | 2008-10-22 | Glaxosmithkline Biolog Sa | Method |
| GB2466025A (en) * | 2008-12-08 | 2010-06-09 | Univ Francois Rabelais De Tour | C3/ITGAM polymorphisms and cancer prognosis |
| GB0917457D0 (en) * | 2009-10-06 | 2009-11-18 | Glaxosmithkline Biolog Sa | Method |
| EP2513336B1 (en) * | 2009-12-16 | 2016-03-02 | Hitachi Chemical Co., Ltd. | Method for characterizing host immune function by ex vivo induction of offensive and defensive immune markers |
| EP2380991A1 (en) | 2010-04-20 | 2011-10-26 | Universitätsklinikum Hamburg-Eppendorf | Method of determining the metastatic potential of a tumor |
| CN106978480A (zh) * | 2010-09-15 | 2017-07-25 | 阿尔玛克诊断有限公司 | 用于癌症的分子诊断试验 |
| KR101287600B1 (ko) * | 2011-01-04 | 2013-07-18 | 주식회사 젠큐릭스 | 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 |
| US9926604B2 (en) | 2011-10-14 | 2018-03-27 | The Regents Of The University Of California | Multiplex PCR-based testing of cutaneous squamous cell carcinoma and pseudoepitheliomatous hyperplasia and methods for distinguishing the same |
| US11242564B2 (en) * | 2012-07-12 | 2022-02-08 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes |
| JO3519B1 (ar) | 2013-01-25 | 2020-07-05 | Amgen Inc | تركيبات أجسام مضادة لأجل cdh19 و cd3 |
| WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
| US11725237B2 (en) | 2013-12-05 | 2023-08-15 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
| EP3082853A2 (en) | 2013-12-20 | 2016-10-26 | The Broad Institute, Inc. | Combination therapy with neoantigen vaccine |
| CA2953703A1 (en) * | 2014-07-03 | 2016-01-07 | University Of Virginia Patent Foundation | Systems and methods for identifying and profiling muscle patterns |
| US20170298443A1 (en) * | 2014-09-25 | 2017-10-19 | Moffitt Genetics Corporation | Prognostic tumor biomarkers |
| WO2016100975A1 (en) * | 2014-12-19 | 2016-06-23 | Massachsetts Institute Ot Technology | Molecular biomarkers for cancer immunotherapy |
| WO2016100977A1 (en) | 2014-12-19 | 2016-06-23 | The Broad Institute Inc. | Methods for profiling the t-cel- receptor repertoire |
| JP6489900B2 (ja) * | 2015-03-30 | 2019-03-27 | 株式会社ジャパンディスプレイ | 入力装置及び表示装置 |
| CR20200476A (es) | 2015-05-20 | 2020-12-02 | Dana Farber Cancer Inst Inc | ANTÍGENOS COMPARTIDOS (Divisional 2017-0584) |
| WO2017011623A1 (en) * | 2015-07-14 | 2017-01-19 | Atossa Genetics Inc. | Transpapillary methods and compositions for treating breast disorders |
| WO2017040520A1 (en) | 2015-08-31 | 2017-03-09 | Hitachi Chemical Co., Ltd. | Molecular methods for assessing urothelial disease |
| WO2018140391A1 (en) | 2017-01-24 | 2018-08-02 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
| JP7457642B2 (ja) | 2017-04-03 | 2024-03-28 | ビオンテック ユーエス インコーポレイテッド | タンパク質抗原およびその使用 |
| TW201930340A (zh) | 2017-12-18 | 2019-08-01 | 美商尼恩醫療公司 | 新抗原及其用途 |
| CA3103983A1 (en) | 2018-06-19 | 2019-12-26 | Biontech Us Inc. | Neoantigens and uses thereof |
| GB201908565D0 (en) * | 2019-06-14 | 2019-07-31 | Cray Innovation Ab | Method of stratifying subjects into sub-groups for therapeutic treatment |
| CN114540504B (zh) * | 2022-04-27 | 2022-07-08 | 广州万德基因医学科技有限公司 | 用于预测肺鳞癌患者免疫疗效的标志物组及系统 |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1001034B (el) * | 1989-07-21 | 1993-03-31 | Ortho Pharma Corp | Μεθοδος διεγερσης του πολλαπλασιασμου λεμφοκυτταρων περιφερειακου αιματος. |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| EP0761231B1 (en) | 1992-06-25 | 2000-01-12 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine composition containing adjuvants |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| EP0772619B2 (en) | 1994-07-15 | 2010-12-08 | The University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| DE69942214D1 (de) | 1998-02-05 | 2010-05-12 | Glaxosmithkline Biolog Sa | Verfahren zur Reinigung oder Herstellung der MAGE Protein |
| DK1104306T3 (da) | 1998-08-10 | 2006-05-22 | Antigenics Inc | Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf |
| CN1201004C (zh) | 1999-01-29 | 2005-05-11 | 考丽克萨有限公司 | HER－2/neu融合蛋白 |
| JP2002538787A (ja) | 1999-03-11 | 2002-11-19 | スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム | 新規化合物 |
| TR200103018T2 (tr) | 1999-04-19 | 2002-02-21 | Beecham Biologicals S.A. Smithkline | İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri. |
| PL209127B1 (pl) | 2000-02-23 | 2011-07-29 | Smithkline Beecham Biolog | Środek farmaceutyczny do stosowania w immunoterapeutycznym leczeniu raka i sposób diagnozowania u pacjenta obecności lub podatności na raka |
| AUPR077900A0 (en) * | 2000-10-13 | 2000-11-09 | Tvw Telethon Institute For Child Health Research | Immunodiagnosis |
| US20020076469A1 (en) * | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
| JP2004529888A (ja) * | 2001-02-26 | 2004-09-30 | ゲゼルシャフト フュア ビオテヒノロジッシェ フォルシュング エムベーハー （ゲーベーエフ） | インターフェロン調節因子−１／ヒトエストロゲン受容体融合タンパク質および癌を治療するためのその使用 |
| WO2002076469A1 (en) * | 2001-03-27 | 2002-10-03 | Baylor College Of Medicine | A novel technology of intracellular delivery of dna oligonucleotides to improve drug activity |
| DE10127572A1 (de) * | 2001-05-30 | 2002-12-05 | Pathoarray Gmbh | Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen |
| US7229774B2 (en) * | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
| JP4424987B2 (ja) * | 2001-09-20 | 2010-03-03 | ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム | Ｅｌｉｓａアッセイを用いた循環する治療抗体、抗原および抗原／抗体複合体の測定 |
| WO2003050257A2 (en) * | 2001-12-06 | 2003-06-19 | University Of Florida | Targeting leukemia cells |
| EP1482795B1 (en) | 2002-02-04 | 2009-11-11 | Corixa Corporation | New immunoeffector compounds |
| US20040248151A1 (en) * | 2002-04-05 | 2004-12-09 | Ventana Medical Systems, Inc. | Method for predicting the response to HER2-directed therapy |
| US20060147477A1 (en) | 2002-06-11 | 2006-07-06 | Glaxo Group Limited | Immunogenic compositions |
| US20040231909A1 (en) * | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| US20050054496A1 (en) * | 2003-02-25 | 2005-03-10 | Harms Robert E. | Coated weight plates, dumbbells and method of manufacture |
| EP1605811A4 (en) * | 2003-02-28 | 2008-06-11 | Bayer Pharmaceuticals Corp | EXPRESSION PROFILES FOR BREAST CANCER AND METHODS OF USE |
| WO2005098037A1 (en) * | 2003-03-07 | 2005-10-20 | Arcturus Bioscience, Inc. | Breast cancer signatures |
| WO2004081564A1 (en) | 2003-03-14 | 2004-09-23 | Peter Maccallum Cancer Institute | Expression profiling of tumours |
| US20040241725A1 (en) * | 2003-03-25 | 2004-12-02 | Wenming Xiao | Lung cancer detection |
| US7598287B2 (en) * | 2003-04-01 | 2009-10-06 | Medical College Of Georgia Research Institute, Inc. | Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities |
| WO2004105573A2 (en) * | 2003-05-21 | 2004-12-09 | The Wistar Institute Of Anatomy And Biology | Method of diagnosis of cancer based on gene expression profiles in cells |
| EP1631689A2 (en) * | 2003-05-28 | 2006-03-08 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| KR101126560B1 (ko) | 2003-05-30 | 2012-04-05 | 도꾜 다이가꾸 | 약제 반응 예측 방법 |
| US20050100933A1 (en) * | 2003-06-18 | 2005-05-12 | Arcturus Bioscience, Inc. | Breast cancer survival and recurrence |
| KR101431312B1 (ko) * | 2003-06-27 | 2014-08-20 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | Ｗｔ1 백신 적응 환자의 선택 방법 |
| PL1668152T3 (pl) * | 2003-08-28 | 2009-06-30 | Ipsogen | Identyfikacja sygnatury ekspresji genów ERBB2 w rakach sutka |
| JP2007507243A (ja) | 2003-10-03 | 2007-03-29 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 遺伝子発現プロファイルおよび使用方法 |
| US20070110710A1 (en) * | 2003-11-05 | 2007-05-17 | New England Medical Center Hospitals, Inc. | Treatment with immunoregulatory t cells |
| WO2005054496A1 (ja) * | 2003-12-02 | 2005-06-16 | Orient Cancer Therapy Co., Ltd. | 細胞動態の検査方法 |
| WO2005059543A1 (en) * | 2003-12-12 | 2005-06-30 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor h963 (h963) |
| WO2005075680A1 (ja) * | 2004-02-09 | 2005-08-18 | Fuso Pharmaceutical Industries, Ltd. | 核酸検出方法およびその利用 |
| US20060195266A1 (en) | 2005-02-25 | 2006-08-31 | Yeatman Timothy J | Methods for predicting cancer outcome and gene signatures for use therein |
| US7332281B2 (en) * | 2004-04-27 | 2008-02-19 | Sagres Discovery, Inc. | Therapeutic targets in cancer |
| DK1782070T3 (da) * | 2004-06-17 | 2011-01-03 | Mannkind Corp | Tumorassocieret antigenprofiler i cancerdiagnostik og immunterapi |
| US8053197B2 (en) * | 2004-07-30 | 2011-11-08 | Oregon Health & Science University | Methods for detecting and treating autoimmune disorders |
| WO2006054129A1 (en) | 2004-11-19 | 2006-05-26 | Institut Gustave Roussy | Improved treatment of cancer by double-stranded rna |
| US20060110371A1 (en) * | 2004-11-23 | 2006-05-25 | Institut Pasteur | Control of indoleamine 2,3 deoxygenase expression and activity |
| BRPI0518734A2 (pt) * | 2004-11-30 | 2008-12-02 | Veridex Llc | prognàstico de cÂncer de pulmço |
| US20070059720A9 (en) * | 2004-12-06 | 2007-03-15 | Suzanne Fuqua | RNA expression profile predicting response to tamoxifen in breast cancer patients |
| WO2006073982A2 (en) * | 2004-12-30 | 2006-07-13 | Regents Of The University Of California | Bispecific molecule comprising ligands for cell-surface protein and t-cell surface protein |
| US7666595B2 (en) | 2005-02-25 | 2010-02-23 | The Brigham And Women's Hospital, Inc. | Biomarkers for predicting prostate cancer progression |
| GB0504302D0 (en) | 2005-03-02 | 2005-04-06 | Univ Dublin | Markers for melanoma |
| JP2008534002A (ja) | 2005-04-01 | 2008-08-28 | エヌシィーシィー テクノロジー ベンチャーズ ピィーティーイー．リミテッド | 乳癌の分類に関する材料および方法 |
| JP2008535853A (ja) * | 2005-04-07 | 2008-09-04 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド | 癌関連遺伝子 |
| EP1869222A4 (en) * | 2005-04-15 | 2010-01-20 | Oncomethylome Sciences S A | METHYLATION MARKERS FOR THE DIAGNOSIS AND TREATMENT OF CANCER |
| EP1910564A1 (en) | 2005-05-13 | 2008-04-16 | Duke University | Gene expression signatures for oncogenic pathway deregulation |
| US20070111257A1 (en) * | 2005-07-07 | 2007-05-17 | Kohne David E | Improved protein expression comparison assay results and applications |
| EP1934599A1 (en) * | 2005-10-11 | 2008-06-25 | Merck Patent GmbH | Egfr dependent modulation of chemokine expression and influence on therapy and diagnosis of tumors and side effects thereof |
| EP1777523A1 (en) * | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
-
2007
- 2007-05-31 US US12/303,213 patent/US20100021424A1/en not_active Abandoned
- 2007-05-31 EP EP11163716A patent/EP2390364A1/en not_active Withdrawn
- 2007-05-31 CA CA002653949A patent/CA2653949A1/en not_active Abandoned
- 2007-05-31 EP EP11163264A patent/EP2390360A1/en not_active Withdrawn
- 2007-05-31 EP EP11162323A patent/EP2392672A1/en not_active Withdrawn
- 2007-05-31 BR BRPI0712497-0A patent/BRPI0712497A2/pt not_active IP Right Cessation
- 2007-05-31 JP JP2009512510A patent/JP2009538607A/ja active Pending
- 2007-05-31 EP EP11163726A patent/EP2390369A1/en not_active Withdrawn
- 2007-05-31 EP EP11163713A patent/EP2390363A1/en not_active Withdrawn
- 2007-05-31 EP EP11163268A patent/EP2392675A1/en not_active Withdrawn
- 2007-05-31 EP EP11163717A patent/EP2390365A1/en not_active Withdrawn
- 2007-05-31 EA EA200802242A patent/EA200802242A1/ru unknown
- 2007-05-31 EP EP11163271A patent/EP2390361A1/en not_active Withdrawn
- 2007-05-31 AU AU2007256383A patent/AU2007256383B2/en not_active Ceased
- 2007-05-31 EP EP11162327A patent/EP2390356A1/en not_active Withdrawn
- 2007-05-31 KR KR1020087031950A patent/KR20090017655A/ko not_active Ceased
- 2007-05-31 EP EP11163261A patent/EP2390358A1/en not_active Withdrawn
- 2007-05-31 EP EP11162325A patent/EP2390354A1/en not_active Withdrawn
- 2007-05-31 EP EP11163720A patent/EP2390367A1/en not_active Withdrawn
- 2007-05-31 EP EP11163252A patent/EP2390357A1/en not_active Withdrawn
- 2007-05-31 EP EP07725789A patent/EP2032719A2/en not_active Withdrawn
- 2007-05-31 AR ARP070102352A patent/AR061136A1/es not_active Application Discontinuation
- 2007-05-31 EP EP11162320A patent/EP2392671A1/en not_active Withdrawn
- 2007-05-31 EP EP11163263A patent/EP2390359A1/en not_active Withdrawn
- 2007-05-31 ES ES10159376.2T patent/ES2539042T3/es active Active
- 2007-05-31 EP EP10159376.2A patent/EP2258874B1/en active Active
- 2007-05-31 EP EP11162324A patent/EP2390353A1/en not_active Withdrawn
- 2007-05-31 EP EP11162326A patent/EP2390355A1/en not_active Withdrawn
- 2007-05-31 PE PE2007000676A patent/PE20080742A1/es not_active Application Discontinuation
- 2007-05-31 CL CL200701571A patent/CL2007001571A1/es unknown
- 2007-05-31 EP EP11162329A patent/EP2392673A1/en not_active Withdrawn
- 2007-05-31 WO PCT/EP2007/004915 patent/WO2007140958A2/en not_active Ceased
- 2007-05-31 EP EP11163277A patent/EP2390362A1/en not_active Withdrawn
- 2007-05-31 MX MX2008015372A patent/MX2008015372A/es not_active Application Discontinuation
- 2007-05-31 EP EP11163719A patent/EP2390366A1/en not_active Withdrawn
- 2007-05-31 EP EP11163722A patent/EP2390368A1/en not_active Withdrawn
- 2007-05-31 TW TW096119645A patent/TW200817680A/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20090017655A (ko) | 환자가 면역치료제에 대한 반응자일지의 여부를 확인하는 방법 | |
| AU2018210695B2 (en) | Molecular subtyping, prognosis, and treatment of bladder cancer | |
| KR101620642B1 (ko) | 항-ｃｄ４０ 항체를 사용한 치료에 대한 ｂ-세포 림프종의 반응성 평가를 위한 방법 및 조성물 | |
| AU2014295980B2 (en) | Methods for the detection and treatment of leukemias that are responsive to DOT1L inhibition | |
| CN109863251B (zh) | 对肺鳞状细胞癌亚型分型的方法 | |
| CN113260633A (zh) | 用于癌症免疫疗法的诊断方法和组合物 | |
| KR100964193B1 (ko) | 간암 예후 마커 | |
| CN101573453A (zh) | 使用生物学途径基因表达分析来预测淋巴结阴性原发性乳腺癌的远处转移的方法 | |
| AU2020201779B2 (en) | Method for using gene expression to determine prognosis of prostate cancer | |
| CN101111768A (zh) | 肺癌预后 | |
| KR20070099564A (ko) | 급성 골수성 백혈병 환자를 평가하는 방법 | |
| KR20100115283A (ko) | 간암 예후 마커 | |
| CN101501218A (zh) | 用于鉴定患者是否将是免疫治疗的反应者的方法 | |
| HK40058894A (en) | Diagnostic methods and compositions for cancer immunotherapy | |
| NZ618191A (en) | Molecular diagnostic test for cancer | |
| NZ618191B2 (en) | Molecular diagnostic test for cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20081230 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20120531 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20131027 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20140825 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20131027 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
Patent event date: 20141124 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20140825 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20150216 Appeal identifier: 2014101007247 Request date: 20141124 |
|
| PJ0801 | Rejection of trial |
Patent event date: 20150216 Patent event code: PJ08011S01D Comment text: Decision on Dismissal of Request for Trial (Dismissal of Decision) Decision date: 20150216 Appeal kind category: Appeal against decision to decline refusal Appeal identifier: 2014101007247 Request date: 20141124 |